DE60316411T2 - Thiazolderivate als npy-rezeptorantagonisten - Google Patents
Thiazolderivate als npy-rezeptorantagonisten Download PDFInfo
- Publication number
- DE60316411T2 DE60316411T2 DE60316411T DE60316411T DE60316411T2 DE 60316411 T2 DE60316411 T2 DE 60316411T2 DE 60316411 T DE60316411 T DE 60316411T DE 60316411 T DE60316411 T DE 60316411T DE 60316411 T2 DE60316411 T2 DE 60316411T2
- Authority
- DE
- Germany
- Prior art keywords
- thiazol
- ylamino
- methyl
- benzoyl
- propyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940044551 receptor antagonist Drugs 0.000 title description 2
- 239000002464 receptor antagonist Substances 0.000 title description 2
- QAYICIQNSGETAS-UHFFFAOYSA-N dazomet Chemical class CN1CSC(=S)N(C)C1 QAYICIQNSGETAS-UHFFFAOYSA-N 0.000 title 1
- -1 C C 1 -C 8 -alkoxy Chemical group 0.000 claims description 238
- 150000001875 compounds Chemical class 0.000 claims description 208
- 238000006243 chemical reaction Methods 0.000 claims description 155
- 238000000034 method Methods 0.000 claims description 76
- 125000000217 alkyl group Chemical group 0.000 claims description 60
- 150000003839 salts Chemical class 0.000 claims description 29
- 229910052739 hydrogen Inorganic materials 0.000 claims description 27
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 27
- 239000001257 hydrogen Substances 0.000 claims description 26
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 20
- 238000011282 treatment Methods 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 19
- 229940086609 Lipase inhibitor Drugs 0.000 claims description 17
- 208000008589 Obesity Diseases 0.000 claims description 16
- 125000003545 alkoxy group Chemical group 0.000 claims description 16
- 150000001408 amides Chemical class 0.000 claims description 16
- 239000003814 drug Substances 0.000 claims description 16
- 235000020824 obesity Nutrition 0.000 claims description 16
- 125000001424 substituent group Chemical group 0.000 claims description 16
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 claims description 15
- 101710151321 Melanostatin Proteins 0.000 claims description 14
- 102100028427 Pro-neuropeptide Y Human genes 0.000 claims description 14
- 229960001243 orlistat Drugs 0.000 claims description 14
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 14
- 229910052736 halogen Inorganic materials 0.000 claims description 13
- 150000002367 halogens Chemical class 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 238000011321 prophylaxis Methods 0.000 claims description 13
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 10
- 208000001647 Renal Insufficiency Diseases 0.000 claims description 10
- 206010003246 arthritis Diseases 0.000 claims description 10
- 206010012601 diabetes mellitus Diseases 0.000 claims description 10
- 201000006370 kidney failure Diseases 0.000 claims description 10
- 125000001544 thienyl group Chemical group 0.000 claims description 10
- 125000004076 pyridyl group Chemical group 0.000 claims description 9
- 208000030814 Eating disease Diseases 0.000 claims description 8
- 208000019454 Feeding and Eating disease Diseases 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 235000014632 disordered eating Nutrition 0.000 claims description 8
- 150000002431 hydrogen Chemical class 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052794 bromium Chemical group 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 6
- OJBJPKNOXBHZGJ-UHFFFAOYSA-N 2-chloro-n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-5-(trifluoromethyl)benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCNS(=O)(=O)C=2C(=CC=C(C=2)C(F)(F)F)Cl)=N1 OJBJPKNOXBHZGJ-UHFFFAOYSA-N 0.000 claims description 6
- JFZKIMSEVKSNHD-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCNC1=NC(C(=O)C=2C(=CC=CC=2)C)=CS1 JFZKIMSEVKSNHD-UHFFFAOYSA-N 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- VSKXSADWIKAJOW-UHFFFAOYSA-N 2-chloro-n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-5-(trifluoromethyl)benzenesulfonamide Chemical compound FC(F)(F)C1=CC=C(Cl)C(S(=O)(=O)NCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)Cl)=C1 VSKXSADWIKAJOW-UHFFFAOYSA-N 0.000 claims description 5
- WSZRBYPVRMTROP-UHFFFAOYSA-N 2-chloro-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-5-(trifluoromethyl)benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC(C(F)(F)F)=CC=C1Cl WSZRBYPVRMTROP-UHFFFAOYSA-N 0.000 claims description 5
- DOAQWUHLLDBVCS-UHFFFAOYSA-N 2-chloro-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]-5-(trifluoromethyl)benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC(C(F)(F)F)=CC=C1Cl DOAQWUHLLDBVCS-UHFFFAOYSA-N 0.000 claims description 5
- BFGZPYGHAVNFFS-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 BFGZPYGHAVNFFS-UHFFFAOYSA-N 0.000 claims description 5
- LNHWQOKFWISJLR-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[5-[[4-methyl-5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCCCNC1=NC(C)=C(C(=O)C=2C(=CC=CC=2)C)S1 LNHWQOKFWISJLR-UHFFFAOYSA-N 0.000 claims description 5
- SEZOMSCCWVONAJ-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 SEZOMSCCWVONAJ-UHFFFAOYSA-N 0.000 claims description 5
- AKHLFPVCUFCQSQ-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[5-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2N=CC=CC=2)S1 AKHLFPVCUFCQSQ-UHFFFAOYSA-N 0.000 claims description 5
- YSYAZDMYCKSANN-UHFFFAOYSA-N 4-methoxy-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 YSYAZDMYCKSANN-UHFFFAOYSA-N 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 5
- YFZMRHFEVGODEE-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-2-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=CS1 YFZMRHFEVGODEE-UHFFFAOYSA-N 0.000 claims description 5
- KYZCONUNJLEHBB-UHFFFAOYSA-N n-[5-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]pentyl]-2-fluorobenzenesulfonamide Chemical compound FC1=CC=CC=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 KYZCONUNJLEHBB-UHFFFAOYSA-N 0.000 claims description 5
- KITOQPGNBHIXGH-UHFFFAOYSA-N n-[5-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]pentyl]-2-methoxy-5-methylbenzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 KITOQPGNBHIXGH-UHFFFAOYSA-N 0.000 claims description 5
- XJTXAAPTCQPFDF-UHFFFAOYSA-N n-[5-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]pentyl]-2-methylbenzenesulfonamide Chemical compound CC1=CC=CC=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 XJTXAAPTCQPFDF-UHFFFAOYSA-N 0.000 claims description 5
- 125000001624 naphthyl group Chemical group 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- WUMYVSGSTKZLKN-UHFFFAOYSA-N 2,5-dimethoxy-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound COC1=CC=C(OC)C(S(=O)(=O)NCCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)C)=C1 WUMYVSGSTKZLKN-UHFFFAOYSA-N 0.000 claims description 4
- MOAWCMYHSCPOHS-UHFFFAOYSA-N 2-chloro-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-4-(trifluoromethyl)benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=C(C(F)(F)F)C=C1Cl MOAWCMYHSCPOHS-UHFFFAOYSA-N 0.000 claims description 4
- HHBPUXHVLPSPRC-UHFFFAOYSA-N 4-chloro-n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C=1C=C(Cl)C=CC=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C HHBPUXHVLPSPRC-UHFFFAOYSA-N 0.000 claims description 4
- MWJPZYAHWVJURU-UHFFFAOYSA-N 5-fluoro-2-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC(F)=CC=C1C MWJPZYAHWVJURU-UHFFFAOYSA-N 0.000 claims description 4
- 125000004104 aryloxy group Chemical group 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- AOMFSYVEJWWWOZ-UHFFFAOYSA-N n,2-dimethyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C=1C=CC=C(C)C=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C AOMFSYVEJWWWOZ-UHFFFAOYSA-N 0.000 claims description 4
- ZJACVTXUARJMKK-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-2-sulfonamide Chemical compound ClC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=CS1 ZJACVTXUARJMKK-UHFFFAOYSA-N 0.000 claims description 4
- WTDLBONHJHWXJS-UHFFFAOYSA-N n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-4-nitrobenzenesulfonamide Chemical compound C=1C=C([N+]([O-])=O)C=CC=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C WTDLBONHJHWXJS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 125000003541 2-chlorobenzoyl group Chemical group ClC1=C(C(=O)*)C=CC=C1 0.000 claims description 3
- KINDPLVJEGXZBU-UHFFFAOYSA-N 5-chloro-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-2-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=C(Cl)S1 KINDPLVJEGXZBU-UHFFFAOYSA-N 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 3
- CSNICAGFSAQDIK-UHFFFAOYSA-N n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]thiophene-2-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCNS(=O)(=O)C1=CC=CS1 CSNICAGFSAQDIK-UHFFFAOYSA-N 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- 238000002560 therapeutic procedure Methods 0.000 claims description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- QPKQMQKFALBADC-UHFFFAOYSA-N 5-chloro-n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-2-sulfonamide Chemical compound C=1C=C(Cl)SC=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C QPKQMQKFALBADC-UHFFFAOYSA-N 0.000 claims 1
- LMUWHAMXLLIQOX-UHFFFAOYSA-N n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-2-sulfonamide Chemical compound C=1C=CSC=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C LMUWHAMXLLIQOX-UHFFFAOYSA-N 0.000 claims 1
- 125000005186 naphthyloxy group Chemical group C1(=CC=CC2=CC=CC=C12)O* 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 290
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 110
- 239000003153 chemical reaction reagent Substances 0.000 description 100
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- 239000002585 base Substances 0.000 description 59
- 239000000203 mixture Substances 0.000 description 57
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 53
- 239000002904 solvent Substances 0.000 description 53
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 52
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 47
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 43
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 40
- HLABGJLUTKJSBA-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-(2-methylphenyl)methanone Chemical compound CC1=CC=CC=C1C(=O)C1=CN=C(NCCCN)S1 HLABGJLUTKJSBA-UHFFFAOYSA-N 0.000 description 33
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 33
- 238000004458 analytical method Methods 0.000 description 29
- 239000000376 reactant Substances 0.000 description 28
- 239000000243 solution Substances 0.000 description 27
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 24
- 239000000047 product Substances 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 23
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 23
- IRVLCEMGFDBWAF-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-(2-chlorophenyl)methanone Chemical compound S1C(NCCCN)=NC=C1C(=O)C1=CC=CC=C1Cl IRVLCEMGFDBWAF-UHFFFAOYSA-N 0.000 description 22
- 239000002253 acid Substances 0.000 description 22
- MWXYNRSDYAGUBL-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-(2-ethylphenyl)methanone Chemical compound CCC1=CC=CC=C1C(=O)C1=CN=C(NCCCN)S1 MWXYNRSDYAGUBL-UHFFFAOYSA-N 0.000 description 21
- 125000000753 cycloalkyl group Chemical group 0.000 description 21
- ZMZRUMCPNAJPPN-UHFFFAOYSA-N tert-butyl n-[3-(dimethylaminomethylidenecarbamothioylamino)propyl]carbamate Chemical compound CN(C)C=NC(=S)NCCCNC(=O)OC(C)(C)C ZMZRUMCPNAJPPN-UHFFFAOYSA-N 0.000 description 21
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 150000007979 thiazole derivatives Chemical class 0.000 description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- NTMQRZKPLYIFMC-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-4-yl]-(2-methylphenyl)methanone Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCN)=N1 NTMQRZKPLYIFMC-UHFFFAOYSA-N 0.000 description 18
- WUPWWMXYQFNPOB-UHFFFAOYSA-N [2-[3-(methylamino)propylamino]-1,3-thiazol-5-yl]-(2-methylphenyl)methanone Chemical compound S1C(NCCCNC)=NC=C1C(=O)C1=CC=CC=C1C WUPWWMXYQFNPOB-UHFFFAOYSA-N 0.000 description 18
- QXLPEATYACFYRX-UHFFFAOYSA-N [2-(2-aminobutylamino)-1,3-thiazol-5-yl]-(2-methylphenyl)methanone Chemical compound S1C(NCC(N)CC)=NC=C1C(=O)C1=CC=CC=C1C QXLPEATYACFYRX-UHFFFAOYSA-N 0.000 description 17
- 150000002148 esters Chemical class 0.000 description 16
- 238000010992 reflux Methods 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000010438 heat treatment Methods 0.000 description 15
- 229940124530 sulfonamide Drugs 0.000 description 15
- 150000003456 sulfonamides Chemical class 0.000 description 15
- KDRUKMQPSTVING-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-(4-methylpyridin-3-yl)methanone Chemical compound CC1=CC=NC=C1C(=O)C1=CN=C(NCCCN)S1 KDRUKMQPSTVING-UHFFFAOYSA-N 0.000 description 14
- 230000002411 adverse Effects 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- NIOKEQAGNVAFRY-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-[2-(trifluoromethyl)phenyl]methanone Chemical compound S1C(NCCCN)=NC=C1C(=O)C1=CC=CC=C1C(F)(F)F NIOKEQAGNVAFRY-UHFFFAOYSA-N 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 13
- 150000003672 ureas Chemical class 0.000 description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- UULOZENNGZPQKV-UHFFFAOYSA-N [2-(5-aminopentylamino)-1,3-thiazol-5-yl]-(2-methylphenyl)methanone Chemical compound CC1=CC=CC=C1C(=O)C1=CN=C(NCCCCCN)S1 UULOZENNGZPQKV-UHFFFAOYSA-N 0.000 description 12
- LJERBHQAGPSVCE-UHFFFAOYSA-N [2-(5-aminopentylamino)-1,3-thiazol-5-yl]-pyridin-2-ylmethanone Chemical compound S1C(NCCCCCN)=NC=C1C(=O)C1=CC=CC=N1 LJERBHQAGPSVCE-UHFFFAOYSA-N 0.000 description 12
- 238000001704 evaporation Methods 0.000 description 12
- 230000008020 evaporation Effects 0.000 description 12
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 12
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 12
- 125000006239 protecting group Chemical group 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 11
- 239000007787 solid Substances 0.000 description 11
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 10
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 10
- 235000013877 carbamide Nutrition 0.000 description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 10
- URTFJWCJQLSNDZ-UHFFFAOYSA-N [2-(2-aminopropylamino)-1,3-thiazol-5-yl]-(2-methylphenyl)methanone Chemical compound S1C(NCC(N)C)=NC=C1C(=O)C1=CC=CC=C1C URTFJWCJQLSNDZ-UHFFFAOYSA-N 0.000 description 9
- UOHJCAWHWKOBBB-UHFFFAOYSA-N [2-(5-aminopentylamino)-1,3-thiazol-5-yl]-(2-chlorophenyl)methanone Chemical compound S1C(NCCCCCN)=NC=C1C(=O)C1=CC=CC=C1Cl UOHJCAWHWKOBBB-UHFFFAOYSA-N 0.000 description 9
- VKGZGKLFAXPKOH-UHFFFAOYSA-N [2-(5-aminopentylamino)-4-methyl-1,3-thiazol-5-yl]-(2-methylphenyl)methanone Chemical compound N1=C(NCCCCCN)SC(C(=O)C=2C(=CC=CC=2)C)=C1C VKGZGKLFAXPKOH-UHFFFAOYSA-N 0.000 description 9
- 125000000524 functional group Chemical group 0.000 description 9
- 125000001188 haloalkyl group Chemical group 0.000 description 9
- URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- FZNCGRZWXLXZSZ-CIQUZCHMSA-N Voglibose Chemical compound OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O FZNCGRZWXLXZSZ-CIQUZCHMSA-N 0.000 description 8
- ZZOBGKHBVUQUMG-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-phenylmethanone Chemical compound S1C(NCCCN)=NC=C1C(=O)C1=CC=CC=C1 ZZOBGKHBVUQUMG-UHFFFAOYSA-N 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- 239000000377 silicon dioxide Substances 0.000 description 8
- XMGAXELQRATLJP-UHFFFAOYSA-N 2-bromo-1-(2-methylphenyl)ethanone Chemical compound CC1=CC=CC=C1C(=O)CBr XMGAXELQRATLJP-UHFFFAOYSA-N 0.000 description 7
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 7
- CBJJKUQHIUQSOF-UHFFFAOYSA-N [2-(2-aminopentylamino)-1,3-thiazol-5-yl]-(2-methylphenyl)methanone Chemical compound S1C(NCC(N)CCC)=NC=C1C(=O)C1=CC=CC=C1C CBJJKUQHIUQSOF-UHFFFAOYSA-N 0.000 description 7
- WOMNFNHXIFSKAE-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-(3-methylthiophen-2-yl)methanone Chemical compound C1=CSC(C(=O)C=2SC(NCCCN)=NC=2)=C1C WOMNFNHXIFSKAE-UHFFFAOYSA-N 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000002775 capsule Substances 0.000 description 7
- 102000005962 receptors Human genes 0.000 description 7
- 108020003175 receptors Proteins 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 7
- ZEYKLMDPUOVUCR-UHFFFAOYSA-N 2-chloro-5-(trifluoromethyl)benzenesulfonyl chloride Chemical compound FC(F)(F)C1=CC=C(Cl)C(S(Cl)(=O)=O)=C1 ZEYKLMDPUOVUCR-UHFFFAOYSA-N 0.000 description 6
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 6
- OFSMIIGNMFFMES-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-(3-methylpyrazin-2-yl)methanone Chemical compound CC1=NC=CN=C1C(=O)C1=CN=C(NCCCN)S1 OFSMIIGNMFFMES-UHFFFAOYSA-N 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 6
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 239000008120 corn starch Substances 0.000 description 6
- 229940099112 cornstarch Drugs 0.000 description 6
- 238000003818 flash chromatography Methods 0.000 description 6
- 125000001072 heteroaryl group Chemical group 0.000 description 6
- 239000012948 isocyanate Substances 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- 238000002953 preparative HPLC Methods 0.000 description 6
- 125000003373 pyrazinyl group Chemical group 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical class ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 238000000844 transformation Methods 0.000 description 6
- OKYSUJVCDXZGKE-UHFFFAOYSA-N 3-fluorobenzenesulfonyl chloride Chemical compound FC1=CC=CC(S(Cl)(=O)=O)=C1 OKYSUJVCDXZGKE-UHFFFAOYSA-N 0.000 description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 5
- BFXHJFKKRGVUMU-UHFFFAOYSA-N 4-fluorobenzenesulfonyl chloride Chemical compound FC1=CC=C(S(Cl)(=O)=O)C=C1 BFXHJFKKRGVUMU-UHFFFAOYSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- LRWWFDOBBGNMAR-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-(2-fluorophenyl)methanone Chemical compound S1C(NCCCN)=NC=C1C(=O)C1=CC=CC=C1F LRWWFDOBBGNMAR-UHFFFAOYSA-N 0.000 description 5
- 150000001805 chlorine compounds Chemical class 0.000 description 5
- 235000019253 formic acid Nutrition 0.000 description 5
- 150000002513 isocyanates Chemical class 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 229920005862 polyol Polymers 0.000 description 5
- 150000003077 polyols Chemical class 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 239000000454 talc Substances 0.000 description 5
- 229910052623 talc Inorganic materials 0.000 description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 5
- OAXSVEFCBLZGCA-UHFFFAOYSA-N 1-chloro-4-(isocyanatomethyl)benzene Chemical compound ClC1=CC=C(CN=C=O)C=C1 OAXSVEFCBLZGCA-UHFFFAOYSA-N 0.000 description 4
- QAYCTBUGKWGQKZ-UHFFFAOYSA-N 2-bromo-1-(2-ethylphenyl)ethanone Chemical compound CCC1=CC=CC=C1C(=O)CBr QAYCTBUGKWGQKZ-UHFFFAOYSA-N 0.000 description 4
- ZSZKAQCISWFDCQ-UHFFFAOYSA-N 2-fluorobenzenesulfonyl chloride Chemical compound FC1=CC=CC=C1S(Cl)(=O)=O ZSZKAQCISWFDCQ-UHFFFAOYSA-N 0.000 description 4
- HDECRAPHCDXMIJ-UHFFFAOYSA-N 2-methylbenzenesulfonyl chloride Chemical compound CC1=CC=CC=C1S(Cl)(=O)=O HDECRAPHCDXMIJ-UHFFFAOYSA-N 0.000 description 4
- PSWURSQHEVUUAF-UHFFFAOYSA-N 3-bromo-1-(2-methylphenyl)propane-1,2-dione Chemical compound CC1=CC=CC=C1C(=O)C(=O)CBr PSWURSQHEVUUAF-UHFFFAOYSA-N 0.000 description 4
- KOWYRMJDDGKFPJ-UHFFFAOYSA-N 3-fluoro-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=CC(F)=C1 KOWYRMJDDGKFPJ-UHFFFAOYSA-N 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- CHEUWNOMIOWVKT-UHFFFAOYSA-N [2-(2-aminoethylamino)-1,3-thiazol-5-yl]-(2-methylphenyl)methanone Chemical compound CC1=CC=CC=C1C(=O)C1=CN=C(NCCN)S1 CHEUWNOMIOWVKT-UHFFFAOYSA-N 0.000 description 4
- UXPWSGDIANFITB-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-(2-methylpyridin-3-yl)methanone Chemical compound CC1=NC=CC=C1C(=O)C1=CN=C(NCCCN)S1 UXPWSGDIANFITB-UHFFFAOYSA-N 0.000 description 4
- KJYVRQXPQPAXAA-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-(3-methylpyridin-2-yl)methanone Chemical compound CC1=CC=CN=C1C(=O)C1=CN=C(NCCCN)S1 KJYVRQXPQPAXAA-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000008298 dragée Substances 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- DWXOPSSXKDXLTE-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-2-methoxy-5-methylbenzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 DWXOPSSXKDXLTE-UHFFFAOYSA-N 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 238000006268 reductive amination reaction Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 239000012453 solvate Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- RJCASWNSDNXOFG-UHFFFAOYSA-N tert-butyl n-[3-[[5-(2-ethylbenzoyl)-4-methyl-1,3-thiazol-2-yl]amino]propyl]carbamate Chemical compound CCC1=CC=CC=C1C(=O)C1=C(C)N=C(NCCCNC(=O)OC(C)(C)C)S1 RJCASWNSDNXOFG-UHFFFAOYSA-N 0.000 description 4
- DXOHSUUIPNCZQI-UHFFFAOYSA-N tert-butyl n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]carbamate Chemical compound CC1=CC=CC=C1C(=O)C1=CN=C(NCCCNC(=O)OC(C)(C)C)S1 DXOHSUUIPNCZQI-UHFFFAOYSA-N 0.000 description 4
- GOVWCIPUHJRWSI-UHFFFAOYSA-N tert-butyl n-[5-(dimethylaminomethylidenecarbamothioylamino)pentyl]carbamate Chemical compound CN(C)C=NC(=S)NCCCCCNC(=O)OC(C)(C)C GOVWCIPUHJRWSI-UHFFFAOYSA-N 0.000 description 4
- VNNLHYZDXIBHKZ-UHFFFAOYSA-N thiophene-2-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CS1 VNNLHYZDXIBHKZ-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- CWAKZVSNHZWYLD-UHFFFAOYSA-N 1-(2-methoxyphenyl)-3-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound COC1=CC=CC=C1NC(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 CWAKZVSNHZWYLD-UHFFFAOYSA-N 0.000 description 3
- QSSSODXQHVWVHW-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-3-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NCC1=CC=CC=C1Cl QSSSODXQHVWVHW-UHFFFAOYSA-N 0.000 description 3
- PKNBXUXRIBBLLD-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-3-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NCC1=CC=CC=C1Cl PKNBXUXRIBBLLD-UHFFFAOYSA-N 0.000 description 3
- OAXUCZMQIVQCCZ-UHFFFAOYSA-N 1-[3-[(5-benzoyl-1,3-thiazol-2-yl)amino]propyl]-3-[(2-chlorophenyl)methyl]urea Chemical compound ClC1=CC=CC=C1CNC(=O)NCCCNC1=NC=C(C(=O)C=2C=CC=CC=2)S1 OAXUCZMQIVQCCZ-UHFFFAOYSA-N 0.000 description 3
- NLVLWUPAOZNTIT-UHFFFAOYSA-N 1-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-thiophen-2-ylurea Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCNC(=O)NC=2SC=CC=2)=N1 NLVLWUPAOZNTIT-UHFFFAOYSA-N 0.000 description 3
- PRPJKGWBYNTXFH-UHFFFAOYSA-N 1-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-[(2-chlorophenyl)methyl]urea Chemical compound ClC1=CC=CC=C1CNC(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 PRPJKGWBYNTXFH-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- SHELADVIRCCTFN-UHFFFAOYSA-N 2,5-dimethoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(OC)C(S(Cl)(=O)=O)=C1 SHELADVIRCCTFN-UHFFFAOYSA-N 0.000 description 3
- WZWWEVCLPKAQTA-UHFFFAOYSA-N 2-bromo-1-(2-chlorophenyl)ethanone Chemical compound ClC1=CC=CC=C1C(=O)CBr WZWWEVCLPKAQTA-UHFFFAOYSA-N 0.000 description 3
- AAAXPHKZEVJBTJ-UHFFFAOYSA-N 2-fluoro-n-[3-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound FC1=CC=CC=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2N=CC=CC=2)S1 AAAXPHKZEVJBTJ-UHFFFAOYSA-N 0.000 description 3
- ZWLLNFYGGZRONL-UHFFFAOYSA-N 2-methyl-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=CC=C1C ZWLLNFYGGZRONL-UHFFFAOYSA-N 0.000 description 3
- LKHBVVSNWUZLQS-UHFFFAOYSA-N 3-fluoro-n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCNS(=O)(=O)C=2C=C(F)C=CC=2)=N1 LKHBVVSNWUZLQS-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- YNXLOPYTAAFMTN-SBUIBGKBSA-N C([C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)C1=CC=C(O)C=C1 Chemical compound C([C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)C1=CC=C(O)C=C1 YNXLOPYTAAFMTN-SBUIBGKBSA-N 0.000 description 3
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- 239000001828 Gelatine Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010020710 Hyperphagia Diseases 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- 239000004367 Lipase Substances 0.000 description 3
- SIKWOTFNWURSAY-UHFFFAOYSA-N Lipstatin Natural products CCCCCCC1C(CC(CC=CCC=CCCCCC)C(=O)OC(CC(C)C)NC=O)OC1=O SIKWOTFNWURSAY-UHFFFAOYSA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- 101100460785 Mus musculus Npy5r gene Proteins 0.000 description 3
- 102100029549 Neuropeptide Y receptor type 5 Human genes 0.000 description 3
- 101710198055 Neuropeptide Y receptor type 5 Proteins 0.000 description 3
- 102000028582 Neuropeptide Y5 receptor Human genes 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 102100029909 Peptide YY Human genes 0.000 description 3
- 108010088847 Peptide YY Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- JROUDTQSBPPYLQ-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-pyridin-2-ylmethanone Chemical compound S1C(NCCCN)=NC=C1C(=O)C1=CC=CC=N1 JROUDTQSBPPYLQ-UHFFFAOYSA-N 0.000 description 3
- JYUMRYFFCLWZKB-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-pyridin-3-ylmethanone Chemical compound S1C(NCCCN)=NC=C1C(=O)C1=CC=CN=C1 JYUMRYFFCLWZKB-UHFFFAOYSA-N 0.000 description 3
- HXSYGKICCSRBIB-UHFFFAOYSA-N [2-(5-aminopentylamino)-1,3-thiazol-5-yl]-pyridin-4-ylmethanone Chemical compound S1C(NCCCCCN)=NC=C1C(=O)C1=CC=NC=C1 HXSYGKICCSRBIB-UHFFFAOYSA-N 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- CPEKAXYCDKETEN-UHFFFAOYSA-N benzoyl isothiocyanate Chemical compound S=C=NC(=O)C1=CC=CC=C1 CPEKAXYCDKETEN-UHFFFAOYSA-N 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical class OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 235000019421 lipase Nutrition 0.000 description 3
- OQMAKWGYQLJJIA-CUOOPAIESA-N lipstatin Chemical compound CCCCCC[C@H]1[C@H](C[C@H](C\C=C/C\C=C/CCCCC)OC(=O)[C@H](CC(C)C)NC=O)OC1=O OQMAKWGYQLJJIA-CUOOPAIESA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- MIIBWJOQSIOOMB-UHFFFAOYSA-N n-[5-[[4-methyl-5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound S1C(C(=O)C=2C(=CC=CC=2)C)=C(C)N=C1NCCCCCNS(=O)(=O)C1=CC=CC=C1 MIIBWJOQSIOOMB-UHFFFAOYSA-N 0.000 description 3
- 231100000989 no adverse effect Toxicity 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- NFVJIZNFGQLJGZ-UHFFFAOYSA-N tert-butyl n-[3-(carbamothioylamino)propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC(N)=S NFVJIZNFGQLJGZ-UHFFFAOYSA-N 0.000 description 3
- OUDAYSKMRFSYPL-UHFFFAOYSA-N tert-butyl n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]carbamate Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCNC(=O)OC(C)(C)C)=N1 OUDAYSKMRFSYPL-UHFFFAOYSA-N 0.000 description 3
- MLGPAZBDMXAXPQ-UHFFFAOYSA-N tert-butyl n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]carbamate Chemical compound S1C(NCCCNC(=O)OC(C)(C)C)=NC=C1C(=O)C1=CC=CC=C1Cl MLGPAZBDMXAXPQ-UHFFFAOYSA-N 0.000 description 3
- XXDOWXAPCWVOIR-UHFFFAOYSA-N tert-butyl n-[5-[[4-methyl-5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]carbamate Chemical compound N1=C(NCCCCCNC(=O)OC(C)(C)C)SC(C(=O)C=2C(=CC=CC=2)C)=C1C XXDOWXAPCWVOIR-UHFFFAOYSA-N 0.000 description 3
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea group Chemical group NC(=S)N UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 3
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 2
- ACUDHGMFARXFEC-UHFFFAOYSA-N 1-(2-fluorophenyl)-3-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCNC(=O)NC=2C(=CC=CC=2)F)=N1 ACUDHGMFARXFEC-UHFFFAOYSA-N 0.000 description 2
- ZLOYRQDQSRDOJJ-UHFFFAOYSA-N 1-(2-fluorophenyl)-3-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1=CC=CC=C1F ZLOYRQDQSRDOJJ-UHFFFAOYSA-N 0.000 description 2
- NSDHSKBWBUOUAK-UHFFFAOYSA-N 1-(2-methylphenyl)propane-1,2-dione Chemical compound CC(=O)C(=O)C1=CC=CC=C1C NSDHSKBWBUOUAK-UHFFFAOYSA-N 0.000 description 2
- GKVFIRRQLHIIPC-UHFFFAOYSA-N 1-(3-fluorophenyl)-3-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1=CC=CC(F)=C1 GKVFIRRQLHIIPC-UHFFFAOYSA-N 0.000 description 2
- AQFBHQKUZMSVDN-UHFFFAOYSA-N 1-(4-fluorophenyl)-3-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1=CC=C(F)C=C1 AQFBHQKUZMSVDN-UHFFFAOYSA-N 0.000 description 2
- SLNKRRYVOOQFGS-UHFFFAOYSA-N 1-(4-methoxyphenyl)-3-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound C1=CC(OC)=CC=C1NC(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=NC=2)C)S1 SLNKRRYVOOQFGS-UHFFFAOYSA-N 0.000 description 2
- AAOOICIMPSGFQW-UHFFFAOYSA-N 1-[3-[(5-benzoyl-1,3-thiazol-2-yl)amino]propyl]-3-butylurea Chemical compound S1C(NCCCNC(=O)NCCCC)=NC=C1C(=O)C1=CC=CC=C1 AAOOICIMPSGFQW-UHFFFAOYSA-N 0.000 description 2
- YGKDPQZDUVIGAG-UHFFFAOYSA-N 1-[3-[(5-benzoyl-1,3-thiazol-2-yl)amino]propyl]-3-cyclohexylurea Chemical compound C1CCCCC1NC(=O)NCCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1 YGKDPQZDUVIGAG-UHFFFAOYSA-N 0.000 description 2
- RFIVJUFBQIEMPG-UHFFFAOYSA-N 1-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-(2-fluorophenyl)urea Chemical compound FC1=CC=CC=C1NC(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 RFIVJUFBQIEMPG-UHFFFAOYSA-N 0.000 description 2
- DZXAXKIYEDKHBE-UHFFFAOYSA-N 1-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-(2-methoxyphenyl)urea Chemical compound COC1=CC=CC=C1NC(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 DZXAXKIYEDKHBE-UHFFFAOYSA-N 0.000 description 2
- WNUMIGMKQDFWGH-UHFFFAOYSA-N 1-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-cyclohexylurea Chemical compound ClC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1CCCCC1 WNUMIGMKQDFWGH-UHFFFAOYSA-N 0.000 description 2
- XYLPWSXBBNVGRZ-UHFFFAOYSA-N 1-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-phenylurea Chemical compound ClC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1=CC=CC=C1 XYLPWSXBBNVGRZ-UHFFFAOYSA-N 0.000 description 2
- VWBOBJKNCOBRCM-UHFFFAOYSA-N 1-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-(2-fluorophenyl)urea Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1=CC=CC=C1F VWBOBJKNCOBRCM-UHFFFAOYSA-N 0.000 description 2
- ZQASEWJBGBFHCP-UHFFFAOYSA-N 1-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-(2-methoxyphenyl)urea Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1=CC=CC=C1OC ZQASEWJBGBFHCP-UHFFFAOYSA-N 0.000 description 2
- MWZMYCMEMNJVKG-UHFFFAOYSA-N 1-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-(3-fluorophenyl)urea Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1=CC=CC(F)=C1 MWZMYCMEMNJVKG-UHFFFAOYSA-N 0.000 description 2
- DMJSYPRBKGPBTF-UHFFFAOYSA-N 1-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-(4-fluorophenyl)urea Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1=CC=C(F)C=C1 DMJSYPRBKGPBTF-UHFFFAOYSA-N 0.000 description 2
- CNNQNDBHQFTCAL-UHFFFAOYSA-N 1-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-phenylurea Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1=CC=CC=C1 CNNQNDBHQFTCAL-UHFFFAOYSA-N 0.000 description 2
- AWHQWAXFXQTYKT-UHFFFAOYSA-N 1-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-phenylurea Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1=CC=CC=C1 AWHQWAXFXQTYKT-UHFFFAOYSA-N 0.000 description 2
- SBFWNZOSVKIUQC-UHFFFAOYSA-N 1-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]-3-phenylurea Chemical compound CC1=CC=NC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1=CC=CC=C1 SBFWNZOSVKIUQC-UHFFFAOYSA-N 0.000 description 2
- GJUMDZHPEQLWBF-UHFFFAOYSA-N 1-butyl-3-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound S1C(NCCCNC(=O)NCCCC)=NC=C1C(=O)C1=CC=CC=C1Cl GJUMDZHPEQLWBF-UHFFFAOYSA-N 0.000 description 2
- CPDDKHYFQSZSRS-UHFFFAOYSA-N 1-butyl-3-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound S1C(NCCCNC(=O)NCCCC)=NC=C1C(=O)C1=CC=CC=C1CC CPDDKHYFQSZSRS-UHFFFAOYSA-N 0.000 description 2
- YEPOYWWMUWFYAB-UHFFFAOYSA-N 1-butyl-3-[3-[[5-(2-fluorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound S1C(NCCCNC(=O)NCCCC)=NC=C1C(=O)C1=CC=CC=C1F YEPOYWWMUWFYAB-UHFFFAOYSA-N 0.000 description 2
- TVWPCINCQLDFEC-UHFFFAOYSA-N 1-butyl-3-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound S1C(NCCCNC(=O)NCCCC)=NC=C1C(=O)C1=CC=CC=C1C TVWPCINCQLDFEC-UHFFFAOYSA-N 0.000 description 2
- ZIWOHVAAECMNCS-UHFFFAOYSA-N 1-butyl-3-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound S1C(NCCCNC(=O)NCCCC)=NC=C1C(=O)C1=CN=CC=C1C ZIWOHVAAECMNCS-UHFFFAOYSA-N 0.000 description 2
- RBZKWCPKEKMMFK-UHFFFAOYSA-N 1-cyclohexyl-3-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1CCCCC1 RBZKWCPKEKMMFK-UHFFFAOYSA-N 0.000 description 2
- SRDSIJXEWOTQJI-UHFFFAOYSA-N 1-cyclohexyl-3-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1CCCCC1 SRDSIJXEWOTQJI-UHFFFAOYSA-N 0.000 description 2
- YSGCZLBZMMHBSD-UHFFFAOYSA-N 1-cyclohexyl-3-[3-[[5-(3-methylpyrazine-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound CC1=NC=CN=C1C(=O)C(S1)=CN=C1NCCCNC(=O)NC1CCCCC1 YSGCZLBZMMHBSD-UHFFFAOYSA-N 0.000 description 2
- SRXLVIURRFNWJE-UHFFFAOYSA-N 1-cyclohexyl-3-[3-[[5-(3-methylthiophene-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]urea Chemical compound C1=CSC(C(=O)C=2SC(NCCCNC(=O)NC3CCCCC3)=NC=2)=C1C SRXLVIURRFNWJE-UHFFFAOYSA-N 0.000 description 2
- CFTYGLKHRAKUGV-UHFFFAOYSA-N 2,4-difluoro-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=C(F)C=C1F CFTYGLKHRAKUGV-UHFFFAOYSA-N 0.000 description 2
- LEZVOGIELICRSN-UHFFFAOYSA-N 2,4-difluoro-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCNS(=O)(=O)C1=CC=C(F)C=C1F LEZVOGIELICRSN-UHFFFAOYSA-N 0.000 description 2
- WDGNOAJJTOUQBO-UHFFFAOYSA-N 2,4-difluoro-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=C(F)C=C1F WDGNOAJJTOUQBO-UHFFFAOYSA-N 0.000 description 2
- GPJDPEACIWGUGH-UHFFFAOYSA-N 2,4-difluoro-n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C=1C=C(F)C=C(F)C=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C GPJDPEACIWGUGH-UHFFFAOYSA-N 0.000 description 2
- FJSAJUXIHJIAMD-UHFFFAOYSA-N 2,4-difluorobenzenesulfonyl chloride Chemical compound FC1=CC=C(S(Cl)(=O)=O)C(F)=C1 FJSAJUXIHJIAMD-UHFFFAOYSA-N 0.000 description 2
- YLEQEZRAROTJCG-UHFFFAOYSA-N 2,5-dimethoxy-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(OC)C(S(=O)(=O)NCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)C)=C1 YLEQEZRAROTJCG-UHFFFAOYSA-N 0.000 description 2
- ORRGXUXRRXWXLW-UHFFFAOYSA-N 2,5-dimethoxy-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound COC1=CC=C(OC)C(S(=O)(=O)NCCCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)C)=C1 ORRGXUXRRXWXLW-UHFFFAOYSA-N 0.000 description 2
- RNQZVOHEWRHJIC-UHFFFAOYSA-N 2,5-dimethyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=C(C)C(S(=O)(=O)NCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)C)=C1 RNQZVOHEWRHJIC-UHFFFAOYSA-N 0.000 description 2
- FJTDZUXNOBFPLK-UHFFFAOYSA-N 2,5-dimethyl-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound CC1=CC=C(C)C(S(=O)(=O)NCCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)C)=C1 FJTDZUXNOBFPLK-UHFFFAOYSA-N 0.000 description 2
- KVSUPNWAHIYYMR-UHFFFAOYSA-N 2,5-dimethyl-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound CC1=CC=C(C)C(S(=O)(=O)NCCCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)C)=C1 KVSUPNWAHIYYMR-UHFFFAOYSA-N 0.000 description 2
- BDVQNNRROZYPLB-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]acetamide Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)CC1=CC=C(Cl)C=C1 BDVQNNRROZYPLB-UHFFFAOYSA-N 0.000 description 2
- JGSQLCCSYDWXQF-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]acetamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)CC1=CC=C(Cl)C=C1 JGSQLCCSYDWXQF-UHFFFAOYSA-N 0.000 description 2
- WJNAMKUUBOUZGJ-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[3-[[5-(3-methylpyrazine-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]acetamide Chemical compound CC1=NC=CN=C1C(=O)C(S1)=CN=C1NCCCNC(=O)CC1=CC=C(Cl)C=C1 WJNAMKUUBOUZGJ-UHFFFAOYSA-N 0.000 description 2
- XXOCECJZAYEVFA-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[3-[[5-(3-methylpyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]acetamide Chemical compound CC1=CC=CN=C1C(=O)C(S1)=CN=C1NCCCNC(=O)CC1=CC=C(Cl)C=C1 XXOCECJZAYEVFA-UHFFFAOYSA-N 0.000 description 2
- JCORZGRCVMFOFS-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]acetamide Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)CC1=CC=C(Cl)C=C1 JCORZGRCVMFOFS-UHFFFAOYSA-N 0.000 description 2
- KWZCBMKXNYOQAK-UHFFFAOYSA-N 2-bromo-1-[2-(trifluoromethyl)phenyl]ethanone Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)CBr KWZCBMKXNYOQAK-UHFFFAOYSA-N 0.000 description 2
- MSPAFCDGLDYAFZ-UHFFFAOYSA-N 2-chloro-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]-5-(trifluoromethyl)benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCNS(=O)(=O)C1=CC(C(F)(F)F)=CC=C1Cl MSPAFCDGLDYAFZ-UHFFFAOYSA-N 0.000 description 2
- AFMUYZPNAFFSFB-UHFFFAOYSA-N 2-chloro-n-[5-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]pentyl]-5-(trifluoromethyl)benzenesulfonamide Chemical compound FC(F)(F)C1=CC=C(Cl)C(S(=O)(=O)NCCCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)Cl)=C1 AFMUYZPNAFFSFB-UHFFFAOYSA-N 0.000 description 2
- BHDKODGZHNTZAP-UHFFFAOYSA-N 2-chloro-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]-4-(trifluoromethyl)benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=C(C(F)(F)F)C=C1Cl BHDKODGZHNTZAP-UHFFFAOYSA-N 0.000 description 2
- XQGSECDVBQTMFJ-UHFFFAOYSA-N 2-chloro-n-[5-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]-5-(trifluoromethyl)benzenesulfonamide Chemical compound FC(F)(F)C1=CC=C(Cl)C(S(=O)(=O)NCCCCCNC=2SC(=CN=2)C(=O)C=2N=CC=CC=2)=C1 XQGSECDVBQTMFJ-UHFFFAOYSA-N 0.000 description 2
- OUNRQXDYSKOWSN-UHFFFAOYSA-N 2-chloro-n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-4-(trifluoromethyl)benzenesulfonamide Chemical compound C=1C=C(C(F)(F)F)C=C(Cl)C=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C OUNRQXDYSKOWSN-UHFFFAOYSA-N 0.000 description 2
- HSQRGUUEONULAV-UHFFFAOYSA-N 2-chloro-n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-5-(trifluoromethyl)benzenesulfonamide Chemical compound C=1C(C(F)(F)F)=CC=C(Cl)C=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C HSQRGUUEONULAV-UHFFFAOYSA-N 0.000 description 2
- AFPVMNCFVUGXPS-UHFFFAOYSA-N 2-fluoro-n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCNC(=O)C=2C(=CC=CC=2)F)=N1 AFPVMNCFVUGXPS-UHFFFAOYSA-N 0.000 description 2
- NTFSHNYHONDVIM-UHFFFAOYSA-N 2-fluoro-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=CC=C1F NTFSHNYHONDVIM-UHFFFAOYSA-N 0.000 description 2
- BVILIQYBUPLNDW-UHFFFAOYSA-N 2-fluoro-n-[3-[[5-(3-methylpyrazine-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=NC=CN=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC=C1F BVILIQYBUPLNDW-UHFFFAOYSA-N 0.000 description 2
- ARTSXBWKTCYPIT-UHFFFAOYSA-N 2-fluoro-n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound FC1=CC=CC=C1C(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C(F)(F)F)S1 ARTSXBWKTCYPIT-UHFFFAOYSA-N 0.000 description 2
- NHDJCPXSUBXJNB-UHFFFAOYSA-N 2-fluoro-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCNS(=O)(=O)C1=CC=CC=C1F NHDJCPXSUBXJNB-UHFFFAOYSA-N 0.000 description 2
- JUTSNQGZRMRXRW-UHFFFAOYSA-N 2-fluoro-n-[5-[[4-methyl-5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound S1C(C(=O)C=2C(=CC=CC=2)C)=C(C)N=C1NCCCCCNS(=O)(=O)C1=CC=CC=C1F JUTSNQGZRMRXRW-UHFFFAOYSA-N 0.000 description 2
- RLQSOYKNCAMXQC-UHFFFAOYSA-N 2-fluoro-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=CC=C1F RLQSOYKNCAMXQC-UHFFFAOYSA-N 0.000 description 2
- PMVXSKZWCQGPLZ-UHFFFAOYSA-N 2-fluoro-n-[5-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound FC1=CC=CC=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2N=CC=CC=2)S1 PMVXSKZWCQGPLZ-UHFFFAOYSA-N 0.000 description 2
- PEMNCOYIOQVWPW-UHFFFAOYSA-N 2-fluoro-n-[5-[[5-(pyridine-4-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound FC1=CC=CC=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2C=CN=CC=2)S1 PEMNCOYIOQVWPW-UHFFFAOYSA-N 0.000 description 2
- YGLLBQZMBGYNNA-UHFFFAOYSA-N 2-fluoro-n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C=1C=CC=C(F)C=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C YGLLBQZMBGYNNA-UHFFFAOYSA-N 0.000 description 2
- XORPFRMEQVCBRF-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[3-[[5-(3-methylpyrazine-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C(=NC=CN=2)C)S1 XORPFRMEQVCBRF-UHFFFAOYSA-N 0.000 description 2
- QMACRGKHADKXMC-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[3-[[5-(3-methylthiophene-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C2=C(C=CS2)C)S1 QMACRGKHADKXMC-UHFFFAOYSA-N 0.000 description 2
- NAUHATNYIYOWFG-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=NC=2)C)S1 NAUHATNYIYOWFG-UHFFFAOYSA-N 0.000 description 2
- VOEHKCJNFHQIEZ-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[3-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2N=CC=CC=2)S1 VOEHKCJNFHQIEZ-UHFFFAOYSA-N 0.000 description 2
- QPKCMFNQLXFCPG-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[3-[[5-(pyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C=NC=CC=2)S1 QPKCMFNQLXFCPG-UHFFFAOYSA-N 0.000 description 2
- DKFJDVSTLOIXJF-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[3-[[5-(pyridine-4-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C=CN=CC=2)S1 DKFJDVSTLOIXJF-UHFFFAOYSA-N 0.000 description 2
- UYOFIWVSBDNTLU-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 UYOFIWVSBDNTLU-UHFFFAOYSA-N 0.000 description 2
- JWRYLFUKNLAXNK-UHFFFAOYSA-N 2-methoxy-5-methyl-n-[5-[[5-(pyridine-4-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2C=CN=CC=2)S1 JWRYLFUKNLAXNK-UHFFFAOYSA-N 0.000 description 2
- BJYNYQGJTZULJI-UHFFFAOYSA-N 2-methoxy-5-methylbenzenesulfonyl chloride Chemical compound COC1=CC=C(C)C=C1S(Cl)(=O)=O BJYNYQGJTZULJI-UHFFFAOYSA-N 0.000 description 2
- NMZLYFXROKLPON-UHFFFAOYSA-N 2-methoxy-n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound COC1=CC=CC=C1C(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C(F)(F)F)S1 NMZLYFXROKLPON-UHFFFAOYSA-N 0.000 description 2
- DWDVXYHFOVWLTK-UHFFFAOYSA-N 2-methyl-n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCNS(=O)(=O)C=2C(=CC=CC=2)C)=N1 DWDVXYHFOVWLTK-UHFFFAOYSA-N 0.000 description 2
- DJWMSAGZMKPRJG-UHFFFAOYSA-N 2-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=CC=C1C DJWMSAGZMKPRJG-UHFFFAOYSA-N 0.000 description 2
- QEKQFBOSOQKUCQ-UHFFFAOYSA-N 2-methyl-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCNS(=O)(=O)C1=CC=CC=C1C QEKQFBOSOQKUCQ-UHFFFAOYSA-N 0.000 description 2
- UJYWVLNMVVCFBO-UHFFFAOYSA-N 2-methyl-n-[5-[[4-methyl-5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound S1C(C(=O)C=2C(=CC=CC=2)C)=C(C)N=C1NCCCCCNS(=O)(=O)C1=CC=CC=C1C UJYWVLNMVVCFBO-UHFFFAOYSA-N 0.000 description 2
- PMGAJJMBNOXHJV-UHFFFAOYSA-N 2-methyl-n-[5-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2N=CC=CC=2)S1 PMGAJJMBNOXHJV-UHFFFAOYSA-N 0.000 description 2
- FARHJHLCCSYQCH-UHFFFAOYSA-N 3,5-dimethoxy-n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound COC1=CC(OC)=CC(C(=O)NCCCNC=2SC=C(N=2)C(=O)C=2C(=CC=CC=2)C)=C1 FARHJHLCCSYQCH-UHFFFAOYSA-N 0.000 description 2
- JSLLQDGKGGWOFF-UHFFFAOYSA-N 3-fluoro-n-[3-[[5-(2-fluorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound FC1=CC=CC(C(=O)NCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)F)=C1 JSLLQDGKGGWOFF-UHFFFAOYSA-N 0.000 description 2
- QSBBYTLVEZSNPR-UHFFFAOYSA-N 3-fluoro-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC(F)=C1 QSBBYTLVEZSNPR-UHFFFAOYSA-N 0.000 description 2
- DLCHUMFICPXSNE-UHFFFAOYSA-N 3-fluoro-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=CC(F)=C1 DLCHUMFICPXSNE-UHFFFAOYSA-N 0.000 description 2
- IJNCQMLRRZTQGK-UHFFFAOYSA-N 3-fluoro-n-[3-[[5-(3-methylpyrazine-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=NC=CN=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC(F)=C1 IJNCQMLRRZTQGK-UHFFFAOYSA-N 0.000 description 2
- OUKXBNHAAGPLSU-UHFFFAOYSA-N 3-fluoro-n-[3-[[5-(3-methylpyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=CN=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC(F)=C1 OUKXBNHAAGPLSU-UHFFFAOYSA-N 0.000 description 2
- FPZUUVFIGQSJCY-UHFFFAOYSA-N 3-fluoro-n-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=NC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC(F)=C1 FPZUUVFIGQSJCY-UHFFFAOYSA-N 0.000 description 2
- BLBMVNXCMDZTAV-UHFFFAOYSA-N 3-fluoro-n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound FC1=CC=CC(C(=O)NCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 BLBMVNXCMDZTAV-UHFFFAOYSA-N 0.000 description 2
- UNYCJWOAUUGNOC-UHFFFAOYSA-N 3-fluoro-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCNS(=O)(=O)C1=CC=CC(F)=C1 UNYCJWOAUUGNOC-UHFFFAOYSA-N 0.000 description 2
- FWSSUWXYSZHKEQ-UHFFFAOYSA-N 3-fluoro-n-[5-[[4-methyl-5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound S1C(C(=O)C=2C(=CC=CC=2)C)=C(C)N=C1NCCCCCNS(=O)(=O)C1=CC=CC(F)=C1 FWSSUWXYSZHKEQ-UHFFFAOYSA-N 0.000 description 2
- VGUYJTBNHCLSQU-UHFFFAOYSA-N 3-fluoro-n-[5-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound FC1=CC=CC(S(=O)(=O)NCCCCCNC=2SC(=CN=2)C(=O)C=2N=CC=CC=2)=C1 VGUYJTBNHCLSQU-UHFFFAOYSA-N 0.000 description 2
- IMUTTXMTIODVAP-UHFFFAOYSA-N 3-fluoro-n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C=1C=CC(F)=CC=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C IMUTTXMTIODVAP-UHFFFAOYSA-N 0.000 description 2
- UGTJQEGHVHSHHW-UHFFFAOYSA-N 3-methoxy-n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=CC(S(=O)(=O)NCCCNC=2SC=C(N=2)C(=O)C=2C(=CC=CC=2)C)=C1 UGTJQEGHVHSHHW-UHFFFAOYSA-N 0.000 description 2
- MSEYOSOAMOYBBP-UHFFFAOYSA-N 3-methoxy-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=CC(S(=O)(=O)NCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)C)=C1 MSEYOSOAMOYBBP-UHFFFAOYSA-N 0.000 description 2
- BYVFTXFUOXGZOS-UHFFFAOYSA-N 3-methoxy-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound COC1=CC=CC(S(=O)(=O)NCCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)C)=C1 BYVFTXFUOXGZOS-UHFFFAOYSA-N 0.000 description 2
- QAEMOTXVKKOTPO-UHFFFAOYSA-N 3-methoxy-n-[5-[[4-methyl-5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound COC1=CC=CC(S(=O)(=O)NCCCCCNC=2SC(=C(C)N=2)C(=O)C=2C(=CC=CC=2)C)=C1 QAEMOTXVKKOTPO-UHFFFAOYSA-N 0.000 description 2
- XRZJCGYOAYGTAM-UHFFFAOYSA-N 3-methoxy-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound COC1=CC=CC(S(=O)(=O)NCCCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)C)=C1 XRZJCGYOAYGTAM-UHFFFAOYSA-N 0.000 description 2
- QMTPDYHSOWLSTA-UHFFFAOYSA-N 3-methoxy-n-[5-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound COC1=CC=CC(S(=O)(=O)NCCCCCNC=2SC(=CN=2)C(=O)C=2N=CC=CC=2)=C1 QMTPDYHSOWLSTA-UHFFFAOYSA-N 0.000 description 2
- AZYHXRZDJAANET-UHFFFAOYSA-N 3-methoxy-n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=CC(S(=O)(=O)N(C)CCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)C)=C1 AZYHXRZDJAANET-UHFFFAOYSA-N 0.000 description 2
- JHJKSEKUZNJKGO-UHFFFAOYSA-N 3-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=CC(S(Cl)(=O)=O)=C1 JHJKSEKUZNJKGO-UHFFFAOYSA-N 0.000 description 2
- FELVCLYBRBKOIV-UHFFFAOYSA-N 4-chloro-n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=C(Cl)C=C1 FELVCLYBRBKOIV-UHFFFAOYSA-N 0.000 description 2
- HAHJSEHYDAOSRD-UHFFFAOYSA-N 4-chloro-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=C(Cl)C=C1 HAHJSEHYDAOSRD-UHFFFAOYSA-N 0.000 description 2
- SUWJIPOLBXHQPQ-UHFFFAOYSA-N 4-chloro-n-[3-[[5-(2-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=NC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=C(Cl)C=C1 SUWJIPOLBXHQPQ-UHFFFAOYSA-N 0.000 description 2
- SMQLAAYSFMCWPP-UHFFFAOYSA-N 4-chloro-n-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=NC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=C(Cl)C=C1 SMQLAAYSFMCWPP-UHFFFAOYSA-N 0.000 description 2
- LDHRVAWSZWENSL-UHFFFAOYSA-N 4-chloro-n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=C(Cl)C=C1 LDHRVAWSZWENSL-UHFFFAOYSA-N 0.000 description 2
- RBIASHUTAREKFQ-UHFFFAOYSA-N 4-fluoro-n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCNS(=O)(=O)C=2C=CC(F)=CC=2)=N1 RBIASHUTAREKFQ-UHFFFAOYSA-N 0.000 description 2
- WSWJBSJLYYLVKZ-UHFFFAOYSA-N 4-fluoro-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=C(F)C=C1 WSWJBSJLYYLVKZ-UHFFFAOYSA-N 0.000 description 2
- DSGPTZDUUPJDBF-UHFFFAOYSA-N 4-fluoro-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=C(F)C=C1 DSGPTZDUUPJDBF-UHFFFAOYSA-N 0.000 description 2
- KMQDWQDTKFFFAO-UHFFFAOYSA-N 4-fluoro-n-[3-[[5-(3-methylpyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=CN=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=C(F)C=C1 KMQDWQDTKFFFAO-UHFFFAOYSA-N 0.000 description 2
- FUIVMWOEGBSDKA-UHFFFAOYSA-N 4-fluoro-n-[3-[[5-(3-methylthiophene-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound C1=CSC(C(=O)C=2SC(NCCCNC(=O)C=3C=CC(F)=CC=3)=NC=2)=C1C FUIVMWOEGBSDKA-UHFFFAOYSA-N 0.000 description 2
- JLIZZBQFWYDUCR-UHFFFAOYSA-N 4-fluoro-n-[3-[[5-(3-methylthiophene-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C1=CSC(C(=O)C=2SC(NCCCNS(=O)(=O)C=3C=CC(F)=CC=3)=NC=2)=C1C JLIZZBQFWYDUCR-UHFFFAOYSA-N 0.000 description 2
- JYTFLWWPEOKZHL-UHFFFAOYSA-N 4-fluoro-n-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=NC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=C(F)C=C1 JYTFLWWPEOKZHL-UHFFFAOYSA-N 0.000 description 2
- DPYZAHFZCJWNAB-UHFFFAOYSA-N 4-fluoro-n-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=NC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=C(F)C=C1 DPYZAHFZCJWNAB-UHFFFAOYSA-N 0.000 description 2
- YZWCMYLSUYRPSE-UHFFFAOYSA-N 4-fluoro-n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound C1=CC(F)=CC=C1C(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C(F)(F)F)S1 YZWCMYLSUYRPSE-UHFFFAOYSA-N 0.000 description 2
- UISBWLSEZLIAAA-UHFFFAOYSA-N 4-fluoro-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCNS(=O)(=O)C1=CC=C(F)C=C1 UISBWLSEZLIAAA-UHFFFAOYSA-N 0.000 description 2
- LNWATIUAAMHVTE-UHFFFAOYSA-N 4-fluoro-n-[5-[[4-methyl-5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound S1C(C(=O)C=2C(=CC=CC=2)C)=C(C)N=C1NCCCCCNS(=O)(=O)C1=CC=C(F)C=C1 LNWATIUAAMHVTE-UHFFFAOYSA-N 0.000 description 2
- DQKMGHGNEMXKOA-UHFFFAOYSA-N 4-fluoro-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=C(F)C=C1 DQKMGHGNEMXKOA-UHFFFAOYSA-N 0.000 description 2
- UMCRKTDSTFMBPE-UHFFFAOYSA-N 4-fluoro-n-[5-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2N=CC=CC=2)S1 UMCRKTDSTFMBPE-UHFFFAOYSA-N 0.000 description 2
- PXVQDASNMGHSPI-UHFFFAOYSA-N 4-fluoro-n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C=1C=C(F)C=CC=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C PXVQDASNMGHSPI-UHFFFAOYSA-N 0.000 description 2
- IDKCSQWCLNOLCX-UHFFFAOYSA-N 4-methoxy-n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCCCNC1=NC(C(=O)C=2C(=CC=CC=2)C)=CS1 IDKCSQWCLNOLCX-UHFFFAOYSA-N 0.000 description 2
- AEKMZWMVHRKKTF-UHFFFAOYSA-N 4-methoxy-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 AEKMZWMVHRKKTF-UHFFFAOYSA-N 0.000 description 2
- SNTNUXXYHVGDIZ-UHFFFAOYSA-N 4-methoxy-n-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound C1=CC(OC)=CC=C1C(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=NC=2)C)S1 SNTNUXXYHVGDIZ-UHFFFAOYSA-N 0.000 description 2
- CPGSBMFULCQOCY-UHFFFAOYSA-N 4-methoxy-n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound C1=CC(OC)=CC=C1C(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C(F)(F)F)S1 CPGSBMFULCQOCY-UHFFFAOYSA-N 0.000 description 2
- DCTIFZQKFZQTEN-UHFFFAOYSA-N 4-methoxy-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 DCTIFZQKFZQTEN-UHFFFAOYSA-N 0.000 description 2
- AEAUDNRXPWREOV-UHFFFAOYSA-N 4-methoxy-n-[5-[[4-methyl-5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCCCCCNC1=NC(C)=C(C(=O)C=2C(=CC=CC=2)C)S1 AEAUDNRXPWREOV-UHFFFAOYSA-N 0.000 description 2
- MWGKAFWNFXUIRU-UHFFFAOYSA-N 4-methoxy-n-[5-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2N=CC=CC=2)S1 MWGKAFWNFXUIRU-UHFFFAOYSA-N 0.000 description 2
- SNWFPLNXFJBURL-UHFFFAOYSA-N 4-methoxy-n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N(C)CCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 SNWFPLNXFJBURL-UHFFFAOYSA-N 0.000 description 2
- DTJVECUKADWGMO-UHFFFAOYSA-N 4-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(S(Cl)(=O)=O)C=C1 DTJVECUKADWGMO-UHFFFAOYSA-N 0.000 description 2
- OAAFKHMFLHLFFI-UHFFFAOYSA-N 5-chloro-2-methoxy-n-[2-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]ethyl]benzenesulfonamide Chemical compound COC1=CC=C(Cl)C=C1S(=O)(=O)NCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 OAAFKHMFLHLFFI-UHFFFAOYSA-N 0.000 description 2
- RXNKNSRSHKILJS-UHFFFAOYSA-N 5-chloro-2-methoxy-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound COC1=CC=C(Cl)C=C1S(=O)(=O)NCCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 RXNKNSRSHKILJS-UHFFFAOYSA-N 0.000 description 2
- FCJGLIMDVOTBLO-UHFFFAOYSA-N 5-chloro-2-methoxybenzenesulfonyl chloride Chemical compound COC1=CC=C(Cl)C=C1S(Cl)(=O)=O FCJGLIMDVOTBLO-UHFFFAOYSA-N 0.000 description 2
- DKBYGHNBXNSNHP-UHFFFAOYSA-N 5-fluoro-2-methyl-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCNS(=O)(=O)C1=CC(F)=CC=C1C DKBYGHNBXNSNHP-UHFFFAOYSA-N 0.000 description 2
- NMEFGKFQJFGAPI-UHFFFAOYSA-N 5-fluoro-2-methyl-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC(F)=CC=C1C NMEFGKFQJFGAPI-UHFFFAOYSA-N 0.000 description 2
- OXTCHANQDNYNGK-UHFFFAOYSA-N 5-fluoro-n,2-dimethyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C=1C(F)=CC=C(C)C=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C OXTCHANQDNYNGK-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 229940127470 Lipase Inhibitors Drugs 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 108050002826 Neuropeptide Y Receptor Proteins 0.000 description 2
- 102000012301 Neuropeptide Y receptor Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- HWQCPMDSRXNUMC-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-(2-methylphenyl)methanone;hydrochloride Chemical compound Cl.CC1=CC=CC=C1C(=O)C1=CN=C(NCCCN)S1 HWQCPMDSRXNUMC-UHFFFAOYSA-N 0.000 description 2
- XYQZXJAAGRMAFB-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-pyridin-4-ylmethanone Chemical compound S1C(NCCCN)=NC=C1C(=O)C1=CC=NC=C1 XYQZXJAAGRMAFB-UHFFFAOYSA-N 0.000 description 2
- LPPBZIXWEXWBCU-UHFFFAOYSA-N [2-(5-aminopentylamino)-4-methyl-1,3-thiazol-5-yl]-(2-methylphenyl)methanone;hydrochloride Chemical compound Cl.N1=C(NCCCCCN)SC(C(=O)C=2C(=CC=CC=2)C)=C1C LPPBZIXWEXWBCU-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- RROBIDXNTUAHFW-UHFFFAOYSA-N benzotriazol-1-yloxy-tris(dimethylamino)phosphanium Chemical compound C1=CC=C2N(O[P+](N(C)C)(N(C)C)N(C)C)N=NC2=C1 RROBIDXNTUAHFW-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- IQXNZQRDCXFGOY-UHFFFAOYSA-N n,2,5-trimethyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C=1C(C)=CC=C(C)C=1S(=O)(=O)N(C)CCCNC(S1)=NC=C1C(=O)C1=CC=CC=C1C IQXNZQRDCXFGOY-UHFFFAOYSA-N 0.000 description 2
- GHAOFSOOXKWGDV-UHFFFAOYSA-N n-[3-[(5-benzoyl-1,3-thiazol-2-yl)amino]propyl]-2-(4-chlorophenyl)acetamide Chemical compound C1=CC(Cl)=CC=C1CC(=O)NCCCNC1=NC=C(C(=O)C=2C=CC=CC=2)S1 GHAOFSOOXKWGDV-UHFFFAOYSA-N 0.000 description 2
- OJRZHVFWAPSBFY-UHFFFAOYSA-N n-[3-[(5-benzoyl-1,3-thiazol-2-yl)amino]propyl]-2-methoxybenzamide Chemical compound COC1=CC=CC=C1C(=O)NCCCNC1=NC=C(C(=O)C=2C=CC=CC=2)S1 OJRZHVFWAPSBFY-UHFFFAOYSA-N 0.000 description 2
- YYLGLNOEICQWBR-UHFFFAOYSA-N n-[3-[(5-benzoyl-1,3-thiazol-2-yl)amino]propyl]pentanamide Chemical compound S1C(NCCCNC(=O)CCCC)=NC=C1C(=O)C1=CC=CC=C1 YYLGLNOEICQWBR-UHFFFAOYSA-N 0.000 description 2
- KDUQQCBJHORHGZ-UHFFFAOYSA-N n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCNC(=O)C=2C=CC=CC=2)=N1 KDUQQCBJHORHGZ-UHFFFAOYSA-N 0.000 description 2
- VWJMMKYGQSGJOJ-UHFFFAOYSA-N n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCNS(=O)(=O)C=2C=CC=CC=2)=N1 VWJMMKYGQSGJOJ-UHFFFAOYSA-N 0.000 description 2
- ZVCPFIVWZOOHLT-UHFFFAOYSA-N n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-2-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C1=CSC(NCCCNS(=O)(=O)C=2SC=CC=2)=N1 ZVCPFIVWZOOHLT-UHFFFAOYSA-N 0.000 description 2
- GHJXLJAXISLFQQ-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-2-fluorobenzamide Chemical compound FC1=CC=CC=C1C(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 GHJXLJAXISLFQQ-UHFFFAOYSA-N 0.000 description 2
- VRFMTAOSALYSBJ-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-2-fluorobenzenesulfonamide Chemical compound FC1=CC=CC=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 VRFMTAOSALYSBJ-UHFFFAOYSA-N 0.000 description 2
- PZYXUWPJVFHEFB-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-2-methylbenzenesulfonamide Chemical compound CC1=CC=CC=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 PZYXUWPJVFHEFB-UHFFFAOYSA-N 0.000 description 2
- LGPCJRBMVMVCKG-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-fluorobenzamide Chemical compound FC1=CC=CC(C(=O)NCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)Cl)=C1 LGPCJRBMVMVCKG-UHFFFAOYSA-N 0.000 description 2
- QMFZBJCTSLQQGY-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-fluorobenzenesulfonamide Chemical compound FC1=CC=CC(S(=O)(=O)NCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)Cl)=C1 QMFZBJCTSLQQGY-UHFFFAOYSA-N 0.000 description 2
- XGDKQVSXYIUCSB-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-methoxybenzenesulfonamide Chemical compound COC1=CC=CC(S(=O)(=O)NCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)Cl)=C1 XGDKQVSXYIUCSB-UHFFFAOYSA-N 0.000 description 2
- JUUSUUGQRYWOGK-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-4-fluorobenzamide Chemical compound C1=CC(F)=CC=C1C(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 JUUSUUGQRYWOGK-UHFFFAOYSA-N 0.000 description 2
- CVIBFSHFWXZIFC-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-4-fluorobenzenesulfonamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 CVIBFSHFWXZIFC-UHFFFAOYSA-N 0.000 description 2
- BCHTWNDZINSXNN-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]-4-methoxybenzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 BCHTWNDZINSXNN-UHFFFAOYSA-N 0.000 description 2
- NSTSQPNRSIILAZ-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound ClC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC=C1 NSTSQPNRSIILAZ-UHFFFAOYSA-N 0.000 description 2
- QRICESIRRMVJLX-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound ClC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=CC=C1 QRICESIRRMVJLX-UHFFFAOYSA-N 0.000 description 2
- IUDJEJKHEOCWKL-UHFFFAOYSA-N n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-2-fluorobenzamide Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC=C1F IUDJEJKHEOCWKL-UHFFFAOYSA-N 0.000 description 2
- OJXQRSRJVALEFN-UHFFFAOYSA-N n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-2-methoxybenzamide Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC=C1OC OJXQRSRJVALEFN-UHFFFAOYSA-N 0.000 description 2
- STGIGBUMNYCRBP-UHFFFAOYSA-N n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-3-fluorobenzamide Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC(F)=C1 STGIGBUMNYCRBP-UHFFFAOYSA-N 0.000 description 2
- LFGVTNVPMOJFCW-UHFFFAOYSA-N n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-4-fluorobenzamide Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=C(F)C=C1 LFGVTNVPMOJFCW-UHFFFAOYSA-N 0.000 description 2
- AGDNRBPJKRVAQM-UHFFFAOYSA-N n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-4-methoxybenzamide Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=C(OC)C=C1 AGDNRBPJKRVAQM-UHFFFAOYSA-N 0.000 description 2
- ZKOZGMOAVFMLLL-UHFFFAOYSA-N n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC=C1 ZKOZGMOAVFMLLL-UHFFFAOYSA-N 0.000 description 2
- SVFAXKGYJMZIID-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]-4-(trifluoromethoxy)benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=C(OC(F)(F)F)C=C1 SVFAXKGYJMZIID-UHFFFAOYSA-N 0.000 description 2
- PVMMQEVHVRXWAC-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC=C1 PVMMQEVHVRXWAC-UHFFFAOYSA-N 0.000 description 2
- IHCQIWIBDLMDQA-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=CC=C1 IHCQIWIBDLMDQA-UHFFFAOYSA-N 0.000 description 2
- BINFHFWZZBYIIX-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]methanesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C1=CN=C(NCCCNS(C)(=O)=O)S1 BINFHFWZZBYIIX-UHFFFAOYSA-N 0.000 description 2
- UODRCDOUVZVOIY-UHFFFAOYSA-N n-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound CC1=CC=NC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC=C1 UODRCDOUVZVOIY-UHFFFAOYSA-N 0.000 description 2
- UJHAUVQZQNIKIV-UHFFFAOYSA-N n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]benzamide Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CC=C1 UJHAUVQZQNIKIV-UHFFFAOYSA-N 0.000 description 2
- MSJIYZHSQNUEDZ-UHFFFAOYSA-N n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]-4-(trifluoromethoxy)benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCNS(=O)(=O)C1=CC=C(OC(F)(F)F)C=C1 MSJIYZHSQNUEDZ-UHFFFAOYSA-N 0.000 description 2
- ALAVHAZSADFRDX-UHFFFAOYSA-N n-[5-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]pentyl]-3-fluorobenzenesulfonamide Chemical compound FC1=CC=CC(S(=O)(=O)NCCCCCNC=2SC(=CN=2)C(=O)C=2C(=CC=CC=2)Cl)=C1 ALAVHAZSADFRDX-UHFFFAOYSA-N 0.000 description 2
- LARGAWHLIYOXMG-UHFFFAOYSA-N n-[5-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]pentyl]-4-fluorobenzenesulfonamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 LARGAWHLIYOXMG-UHFFFAOYSA-N 0.000 description 2
- HXONOZNWCHFJNQ-UHFFFAOYSA-N n-[5-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]pentyl]-4-methoxybenzenesulfonamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCCCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)Cl)S1 HXONOZNWCHFJNQ-UHFFFAOYSA-N 0.000 description 2
- CMXPTFSTEJBSRW-UHFFFAOYSA-N n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=CC=C1 CMXPTFSTEJBSRW-UHFFFAOYSA-N 0.000 description 2
- DHZWSSFNWJHQLC-UHFFFAOYSA-N n-[5-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]benzenesulfonamide Chemical compound C=1C=CC=NC=1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=CC=C1 DHZWSSFNWJHQLC-UHFFFAOYSA-N 0.000 description 2
- DASJFYAPNPUBGG-UHFFFAOYSA-N naphthalene-1-sulfonyl chloride Chemical compound C1=CC=C2C(S(=O)(=O)Cl)=CC=CC2=C1 DASJFYAPNPUBGG-UHFFFAOYSA-N 0.000 description 2
- 239000007922 nasal spray Substances 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- XGISHOFUAFNYQF-UHFFFAOYSA-N pentanoyl chloride Chemical compound CCCCC(Cl)=O XGISHOFUAFNYQF-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- 239000002287 radioligand Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- DPLOGSUBQDREOU-UHFFFAOYSA-N tert-butyl n-(5-aminopentyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCCCCN DPLOGSUBQDREOU-UHFFFAOYSA-N 0.000 description 2
- SRTMCAQUUMOZJY-UHFFFAOYSA-N tert-butyl n-(5-isothiocyanatopentyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCCCCN=C=S SRTMCAQUUMOZJY-UHFFFAOYSA-N 0.000 description 2
- DOOZXVIPVZDJLE-UHFFFAOYSA-N tert-butyl n-[2-(carbamothioylamino)ethyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCNC(N)=S DOOZXVIPVZDJLE-UHFFFAOYSA-N 0.000 description 2
- RTFMYZSSXDLWMJ-UHFFFAOYSA-N tert-butyl n-[2-(dimethylaminomethylidenecarbamothioylamino)ethyl]carbamate Chemical compound CN(C)C=NC(=S)NCCNC(=O)OC(C)(C)C RTFMYZSSXDLWMJ-UHFFFAOYSA-N 0.000 description 2
- MCXNPYKTIYZKRN-UHFFFAOYSA-N tert-butyl n-[2-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]ethyl]carbamate Chemical compound CC1=CC=CC=C1C(=O)C1=CN=C(NCCNC(=O)OC(C)(C)C)S1 MCXNPYKTIYZKRN-UHFFFAOYSA-N 0.000 description 2
- OFAHEFCGJIAWGQ-UHFFFAOYSA-N tert-butyl n-[3-(1-aminoethylidenecarbamothioylamino)propyl]carbamate Chemical compound CC(N)=NC(=S)NCCCNC(=O)OC(C)(C)C OFAHEFCGJIAWGQ-UHFFFAOYSA-N 0.000 description 2
- BPBRDGJKJKFCIS-UHFFFAOYSA-N tert-butyl n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]carbamate Chemical compound CCC1=CC=CC=C1C(=O)C1=CN=C(NCCCNC(=O)OC(C)(C)C)S1 BPBRDGJKJKFCIS-UHFFFAOYSA-N 0.000 description 2
- KACWLLGFWIKWFI-UHFFFAOYSA-N tert-butyl n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]carbamate Chemical compound S1C(NCCCNC(=O)OC(C)(C)C)=NC=C1C(=O)C1=CC=CC=C1C(F)(F)F KACWLLGFWIKWFI-UHFFFAOYSA-N 0.000 description 2
- FOSNMUDKTWTHAZ-UHFFFAOYSA-N tert-butyl n-[4-(carbamothioylamino)butyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCCNC(N)=S FOSNMUDKTWTHAZ-UHFFFAOYSA-N 0.000 description 2
- IMJGYYRUPQWBGK-UHFFFAOYSA-N tert-butyl n-[4-(dimethylaminomethylidenecarbamothioylamino)butyl]carbamate Chemical compound CN(C)C=NC(=S)NCCCCNC(=O)OC(C)(C)C IMJGYYRUPQWBGK-UHFFFAOYSA-N 0.000 description 2
- GHXOECQNXFISTB-UHFFFAOYSA-N tert-butyl n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]carbamate Chemical compound CC1=CC=CC=C1C(=O)C1=CN=C(NCCCCNC(=O)OC(C)(C)C)S1 GHXOECQNXFISTB-UHFFFAOYSA-N 0.000 description 2
- OQIPOXOZOFBYER-UHFFFAOYSA-N tert-butyl n-[5-(1-aminoethylidenecarbamothioylamino)pentyl]carbamate Chemical compound CC(N)=NC(=S)NCCCCCNC(=O)OC(C)(C)C OQIPOXOZOFBYER-UHFFFAOYSA-N 0.000 description 2
- SYQQSNJVINBWHS-UHFFFAOYSA-N tert-butyl n-[5-(carbamothioylamino)pentyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCCCNC(N)=S SYQQSNJVINBWHS-UHFFFAOYSA-N 0.000 description 2
- JNPPFAKKQHNTEA-UHFFFAOYSA-N tert-butyl n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]carbamate Chemical compound S1C(NCCCN(C)C(=O)OC(C)(C)C)=NC=C1C(=O)C1=CC=CC=C1C JNPPFAKKQHNTEA-UHFFFAOYSA-N 0.000 description 2
- 125000001302 tertiary amino group Chemical group 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 150000003585 thioureas Chemical class 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 1
- APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 1
- WRLPDLDAOMBERO-UHFFFAOYSA-N 1-(2-methylphenyl)propan-2-one Chemical compound CC(=O)CC1=CC=CC=C1C WRLPDLDAOMBERO-UHFFFAOYSA-N 0.000 description 1
- LCEINQHGZAFADC-UHFFFAOYSA-N 1-(4-methylpyridin-3-yl)ethanone Chemical compound CC(=O)C1=CN=CC=C1C LCEINQHGZAFADC-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- SUVCZZADQDCIEQ-UHFFFAOYSA-N 1-isocyanato-2-methoxybenzene Chemical compound COC1=CC=CC=C1N=C=O SUVCZZADQDCIEQ-UHFFFAOYSA-N 0.000 description 1
- RVXJENGCKRCGJC-UHFFFAOYSA-N 2,2,2-trifluoro-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]ethanesulfonamide Chemical compound CC1=CC=CC=C1C(=O)C1=CN=C(NCCCNS(=O)(=O)CC(F)(F)F)S1 RVXJENGCKRCGJC-UHFFFAOYSA-N 0.000 description 1
- CXCHEKCRJQRVNG-UHFFFAOYSA-N 2,2,2-trifluoroethanesulfonyl chloride Chemical compound FC(F)(F)CS(Cl)(=O)=O CXCHEKCRJQRVNG-UHFFFAOYSA-N 0.000 description 1
- FZVZUIBYLZZOEW-UHFFFAOYSA-N 2,5-dimethylbenzenesulfonyl chloride Chemical compound CC1=CC=C(C)C(S(Cl)(=O)=O)=C1 FZVZUIBYLZZOEW-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- DBZAKQWXICEWNW-UHFFFAOYSA-N 2-acetylpyrazine Chemical compound CC(=O)C1=CN=CC=N1 DBZAKQWXICEWNW-UHFFFAOYSA-N 0.000 description 1
- QDNWNJSLWKHNTM-UHFFFAOYSA-N 2-bromo-1-(2-fluorophenyl)ethanone Chemical compound FC1=CC=CC=C1C(=O)CBr QDNWNJSLWKHNTM-UHFFFAOYSA-N 0.000 description 1
- SERFREJMOOXTKQ-UHFFFAOYSA-N 2-bromo-1-(2-methylpyridin-3-yl)ethanone Chemical compound CC1=NC=CC=C1C(=O)CBr SERFREJMOOXTKQ-UHFFFAOYSA-N 0.000 description 1
- QIVYNRHVDLZMHM-UHFFFAOYSA-N 2-bromo-1-(3-methylpyrazin-2-yl)ethanone Chemical compound CC1=NC=CN=C1C(=O)CBr QIVYNRHVDLZMHM-UHFFFAOYSA-N 0.000 description 1
- YPHASTWUTGSZAQ-UHFFFAOYSA-N 2-bromo-1-(3-methylpyrazin-2-yl)ethanone;dihydrobromide Chemical compound Br.Br.CC1=NC=CN=C1C(=O)CBr YPHASTWUTGSZAQ-UHFFFAOYSA-N 0.000 description 1
- MFKZMURKFNOBQN-UHFFFAOYSA-N 2-bromo-1-(3-methylpyridin-2-yl)ethanone Chemical compound CC1=CC=CN=C1C(=O)CBr MFKZMURKFNOBQN-UHFFFAOYSA-N 0.000 description 1
- YUTFYMWVGAJBOG-UHFFFAOYSA-N 2-bromo-1-(3-methylthiophen-2-yl)ethanone Chemical compound CC=1C=CSC=1C(=O)CBr YUTFYMWVGAJBOG-UHFFFAOYSA-N 0.000 description 1
- YWTJLRUGIICPMN-UHFFFAOYSA-N 2-bromo-1-(4-methylpyridin-3-yl)ethanone Chemical compound CC1=CC=NC=C1C(=O)CBr YWTJLRUGIICPMN-UHFFFAOYSA-N 0.000 description 1
- OVQVUSADZFZNNS-UHFFFAOYSA-N 2-bromo-1-(4-methylpyridin-3-yl)ethanone;hydrobromide Chemical compound Br.CC1=CC=NC=C1C(=O)CBr OVQVUSADZFZNNS-UHFFFAOYSA-N 0.000 description 1
- WPDWOCRJBPXJFM-UHFFFAOYSA-N 2-bromo-1-phenylpropan-1-one Chemical compound CC(Br)C(=O)C1=CC=CC=C1 WPDWOCRJBPXJFM-UHFFFAOYSA-N 0.000 description 1
- DNPMOGQMEOPVNT-UHFFFAOYSA-N 2-bromo-1-pyridin-2-ylethanone Chemical compound BrCC(=O)C1=CC=CC=N1 DNPMOGQMEOPVNT-UHFFFAOYSA-N 0.000 description 1
- BYKVUGZUYJUSKD-UHFFFAOYSA-N 2-bromo-1-pyridin-2-ylethanone;hydron;bromide Chemical compound [Br-].BrCC(=O)C1=CC=CC=[NH+]1 BYKVUGZUYJUSKD-UHFFFAOYSA-N 0.000 description 1
- WDTSYONULAZKIE-UHFFFAOYSA-N 2-bromo-1-pyridin-3-ylethanone;hydron;bromide Chemical compound [Br-].BrCC(=O)C1=CC=C[NH+]=C1 WDTSYONULAZKIE-UHFFFAOYSA-N 0.000 description 1
- NAFCUKZZHZYPKB-UHFFFAOYSA-N 2-bromo-1-pyridin-4-ylethanone Chemical compound BrCC(=O)C1=CC=NC=C1 NAFCUKZZHZYPKB-UHFFFAOYSA-N 0.000 description 1
- RGALBQILADNMKA-UHFFFAOYSA-N 2-bromo-1-pyridin-4-ylethanone;hydron;bromide Chemical compound Br.BrCC(=O)C1=CC=NC=C1 RGALBQILADNMKA-UHFFFAOYSA-N 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- ZWDVQMVZZYIAHO-UHFFFAOYSA-N 2-fluorobenzaldehyde Chemical compound FC1=CC=CC=C1C=O ZWDVQMVZZYIAHO-UHFFFAOYSA-N 0.000 description 1
- GWLVDKRVBWCWBK-UHFFFAOYSA-N 2-methoxy-n,5-dimethyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(C)C=C1S(=O)(=O)N(C)CCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 GWLVDKRVBWCWBK-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-M 2-methylbutyrate Chemical compound CCC(C)C([O-])=O WLAMNBDJUVNPJU-UHFFFAOYSA-M 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- ZADFLMBIZVVJJC-UHFFFAOYSA-N 3-(carbamothioylamino)propylcarbamic acid Chemical compound NC(=S)NCCCNC(O)=O ZADFLMBIZVVJJC-UHFFFAOYSA-N 0.000 description 1
- ZYNVAKXJHUHHRL-UHFFFAOYSA-N 3-(dimethylaminomethylidenecarbamothioylamino)propylcarbamic acid Chemical compound CN(C)C=NC(=S)NCCCNC(O)=O ZYNVAKXJHUHHRL-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SYVNVEGIRVXRQH-UHFFFAOYSA-N 3-fluorobenzoyl chloride Chemical compound FC1=CC=CC(C(Cl)=O)=C1 SYVNVEGIRVXRQH-UHFFFAOYSA-N 0.000 description 1
- AJSVPEVDFBYRCH-UHFFFAOYSA-N 3-methylthiophene-2-carbonyl chloride Chemical compound CC=1C=CSC=1C(Cl)=O AJSVPEVDFBYRCH-UHFFFAOYSA-N 0.000 description 1
- HIUODRBTXRPRPJ-UHFFFAOYSA-N 4-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 HIUODRBTXRPRPJ-UHFFFAOYSA-N 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- WRTZIANSYNWWSU-UHFFFAOYSA-N 5-chloro-2-methoxy-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(Cl)C=C1S(=O)(=O)NCCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 WRTZIANSYNWWSU-UHFFFAOYSA-N 0.000 description 1
- XKPOMJZICCJAOO-UHFFFAOYSA-N 5-chloro-2-methoxy-n-methyl-n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]benzenesulfonamide Chemical compound COC1=CC=C(Cl)C=C1S(=O)(=O)N(C)CCCNC1=NC=C(C(=O)C=2C(=CC=CC=2)C)S1 XKPOMJZICCJAOO-UHFFFAOYSA-N 0.000 description 1
- NTVUNWJNKCLECN-UHFFFAOYSA-N 5-chloro-n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]thiophene-2-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCNS(=O)(=O)C1=CC=C(Cl)S1 NTVUNWJNKCLECN-UHFFFAOYSA-N 0.000 description 1
- JUXFNJLQDACSKI-UHFFFAOYSA-N 5-chloro-n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]thiophene-2-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=C(Cl)S1 JUXFNJLQDACSKI-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- USQUBBKCLMLHPH-UHFFFAOYSA-N CC(C=CC=C1)=C1C(C1=CN=C(NCCCNC)S1)=O.OS(C1=CC=CS1)(=O)=O Chemical compound CC(C=CC=C1)=C1C(C1=CN=C(NCCCNC)S1)=O.OS(C1=CC=CS1)(=O)=O USQUBBKCLMLHPH-UHFFFAOYSA-N 0.000 description 1
- QYOVMAREBTZLBT-KTKRTIGZSA-N CCCCCCCC\C=C/CCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO QYOVMAREBTZLBT-KTKRTIGZSA-N 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 1
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 1
- 240000001414 Eucalyptus viminalis Species 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 102100031416 Gastric triacylglycerol lipase Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229940116685 Neuropeptide receptor antagonist Drugs 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- SWLVQTOKBKJBBC-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-4-yl]-(2-methylphenyl)methanone;hydrochloride Chemical compound Cl.CC1=CC=CC=C1C(=O)C1=CSC(NCCCN)=N1 SWLVQTOKBKJBBC-UHFFFAOYSA-N 0.000 description 1
- ZTMXYVYJBJNHBX-UHFFFAOYSA-N [2-(3-aminopropylamino)-1,3-thiazol-5-yl]-phenylmethanone;hydrochloride Chemical compound Cl.S1C(NCCCN)=NC=C1C(=O)C1=CC=CC=C1 ZTMXYVYJBJNHBX-UHFFFAOYSA-N 0.000 description 1
- MQPDCTSISQXGEG-UHFFFAOYSA-N [2-(4-aminobutylamino)-1,3-thiazol-5-yl]-(2-methylphenyl)methanone Chemical compound CC1=CC=CC=C1C(=O)C1=CN=C(NCCCCN)S1 MQPDCTSISQXGEG-UHFFFAOYSA-N 0.000 description 1
- NKKNUTNYVWUZRZ-UHFFFAOYSA-N [2-[3-(tert-butylsulfamoylamino)propylamino]-1,3-thiazol-5-yl]-(2-methylphenyl)methanone Chemical compound CC1=CC=CC=C1C(=O)C1=CN=C(NCCCNS(=O)(=O)NC(C)(C)C)S1 NKKNUTNYVWUZRZ-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 229950003476 aminothiazole Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000021229 appetite regulation Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004473 dialkylaminocarbonyl group Chemical group 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- FRYHCSODNHYDPU-UHFFFAOYSA-N ethanesulfonyl chloride Chemical compound CCS(Cl)(=O)=O FRYHCSODNHYDPU-UHFFFAOYSA-N 0.000 description 1
- WCQOBLXWLRDEQA-UHFFFAOYSA-N ethanimidamide;hydrochloride Chemical compound Cl.CC(N)=N WCQOBLXWLRDEQA-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 108010091264 gastric triacylglycerol lipase Proteins 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000011551 log transformation method Methods 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000006431 methyl cyclopropyl group Chemical group 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- IJLOYOGOEAZOOI-UHFFFAOYSA-N n-[2-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]ethyl]thiophene-2-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCNS(=O)(=O)C1=CC=CS1 IJLOYOGOEAZOOI-UHFFFAOYSA-N 0.000 description 1
- MDYPXZPOLBFNSJ-UHFFFAOYSA-N n-[2-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]ethyl]thiophene-3-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCNS(=O)(=O)C1=CSC=C1 MDYPXZPOLBFNSJ-UHFFFAOYSA-N 0.000 description 1
- JMDLNFVTZKHRSG-UHFFFAOYSA-N n-[3-[[4-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]pentanamide Chemical compound S1C(NCCCNC(=O)CCCC)=NC(C(=O)C=2C(=CC=CC=2)C)=C1 JMDLNFVTZKHRSG-UHFFFAOYSA-N 0.000 description 1
- BZPMYYTZDYONSN-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]pentanamide Chemical compound S1C(NCCCNC(=O)CCCC)=NC=C1C(=O)C1=CC=CC=C1Cl BZPMYYTZDYONSN-UHFFFAOYSA-N 0.000 description 1
- YFBUTSMRVCJUQT-UHFFFAOYSA-N n-[3-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-2-carboxamide Chemical compound ClC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CS1 YFBUTSMRVCJUQT-UHFFFAOYSA-N 0.000 description 1
- CYRHNDJEOHDEOK-UHFFFAOYSA-N n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]cyclohexanecarboxamide Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1CCCCC1 CYRHNDJEOHDEOK-UHFFFAOYSA-N 0.000 description 1
- PIALWSQMXNEGMK-UHFFFAOYSA-N n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]pentanamide Chemical compound S1C(NCCCNC(=O)CCCC)=NC=C1C(=O)C1=CC=CC=C1CC PIALWSQMXNEGMK-UHFFFAOYSA-N 0.000 description 1
- JGAGAPBMGQVKOG-UHFFFAOYSA-N n-[3-[[5-(2-ethylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-2-carboxamide Chemical compound CCC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CS1 JGAGAPBMGQVKOG-UHFFFAOYSA-N 0.000 description 1
- QXWYADHLHXGOQZ-UHFFFAOYSA-N n-[3-[[5-(2-ethylbenzoyl)-4-methyl-1,3-thiazol-2-yl]amino]propyl]-2-methoxy-5-methylbenzenesulfonamide Chemical compound CCC1=CC=CC=C1C(=O)C1=C(C)N=C(NCCCNS(=O)(=O)C=2C(=CC=C(C)C=2)OC)S1 QXWYADHLHXGOQZ-UHFFFAOYSA-N 0.000 description 1
- DFWQYFXCFAQVIW-UHFFFAOYSA-N n-[3-[[5-(2-ethylbenzoyl)-4-methyl-1,3-thiazol-2-yl]amino]propyl]naphthalene-1-sulfonamide Chemical compound CCC1=CC=CC=C1C(=O)C1=C(C)N=C(NCCCNS(=O)(=O)C=2C3=CC=CC=C3C=CC=2)S1 DFWQYFXCFAQVIW-UHFFFAOYSA-N 0.000 description 1
- UFOXFMMACDHCDF-UHFFFAOYSA-N n-[3-[[5-(2-fluorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]pentanamide Chemical compound S1C(NCCCNC(=O)CCCC)=NC=C1C(=O)C1=CC=CC=C1F UFOXFMMACDHCDF-UHFFFAOYSA-N 0.000 description 1
- BKFPHKDAHBFTGB-UHFFFAOYSA-N n-[3-[[5-(2-fluorobenzoyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-2-carboxamide Chemical compound FC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CS1 BKFPHKDAHBFTGB-UHFFFAOYSA-N 0.000 description 1
- NKLDGLSGKVBNQL-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]acetamide Chemical compound S1C(NCCCNC(=O)C)=NC=C1C(=O)C1=CC=CC=C1C NKLDGLSGKVBNQL-UHFFFAOYSA-N 0.000 description 1
- XAZPTIBQKUCAOL-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]cyclohexanecarboxamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1CCCCC1 XAZPTIBQKUCAOL-UHFFFAOYSA-N 0.000 description 1
- NMMKMDDAVQJVGL-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]ethanesulfonamide Chemical compound S1C(NCCCNS(=O)(=O)CC)=NC=C1C(=O)C1=CC=CC=C1C NMMKMDDAVQJVGL-UHFFFAOYSA-N 0.000 description 1
- XAUPPQXIJPMECL-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]naphthalene-1-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CC=CC2=CC=CC=C12 XAUPPQXIJPMECL-UHFFFAOYSA-N 0.000 description 1
- VIPFKXFEWJQKIM-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]pentanamide Chemical compound S1C(NCCCNC(=O)CCCC)=NC=C1C(=O)C1=CC=CC=C1C VIPFKXFEWJQKIM-UHFFFAOYSA-N 0.000 description 1
- PPBODAZRFDUESI-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]propane-2-sulfonamide Chemical compound S1C(NCCCNS(=O)(=O)C(C)C)=NC=C1C(=O)C1=CC=CC=C1C PPBODAZRFDUESI-UHFFFAOYSA-N 0.000 description 1
- SCNYPEXSBVGWSU-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-2-carboxamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CS1 SCNYPEXSBVGWSU-UHFFFAOYSA-N 0.000 description 1
- BCVXUONYYPLTMS-UHFFFAOYSA-N n-[3-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-3-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNS(=O)(=O)C1=CSC=C1 BCVXUONYYPLTMS-UHFFFAOYSA-N 0.000 description 1
- OSUMJWPGLFGYQC-UHFFFAOYSA-N n-[3-[[5-(2-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]pentanamide Chemical compound S1C(NCCCNC(=O)CCCC)=NC=C1C(=O)C1=CC=CN=C1C OSUMJWPGLFGYQC-UHFFFAOYSA-N 0.000 description 1
- BNVUQSGVYGNHCT-UHFFFAOYSA-N n-[3-[[5-(3-methylpyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]thiophene-2-carboxamide Chemical compound CC1=CC=CN=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CS1 BNVUQSGVYGNHCT-UHFFFAOYSA-N 0.000 description 1
- BUGRNXOULOEXJF-UHFFFAOYSA-N n-[3-[[5-(3-methylthiophene-2-carbonyl)-1,3-thiazol-2-yl]amino]propyl]pentanamide Chemical compound S1C(NCCCNC(=O)CCCC)=NC=C1C(=O)C1=C(C)C=CS1 BUGRNXOULOEXJF-UHFFFAOYSA-N 0.000 description 1
- OXYYULFVWWPBPX-UHFFFAOYSA-N n-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]cyclohexanecarboxamide Chemical compound CC1=CC=NC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1CCCCC1 OXYYULFVWWPBPX-UHFFFAOYSA-N 0.000 description 1
- JMZRMSFVFUJWID-UHFFFAOYSA-N n-[3-[[5-(4-methylpyridine-3-carbonyl)-1,3-thiazol-2-yl]amino]propyl]pentanamide Chemical compound S1C(NCCCNC(=O)CCCC)=NC=C1C(=O)C1=CN=CC=C1C JMZRMSFVFUJWID-UHFFFAOYSA-N 0.000 description 1
- CDFHAQYEQXIKKM-UHFFFAOYSA-N n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]cyclohexanecarboxamide Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1CCCCC1 CDFHAQYEQXIKKM-UHFFFAOYSA-N 0.000 description 1
- YOFIRBSTGKQMGB-UHFFFAOYSA-N n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]pentanamide Chemical compound S1C(NCCCNC(=O)CCCC)=NC=C1C(=O)C1=CC=CC=C1C(F)(F)F YOFIRBSTGKQMGB-UHFFFAOYSA-N 0.000 description 1
- SEWOSXUFZVIYDC-UHFFFAOYSA-N n-[3-[[5-[2-(trifluoromethyl)benzoyl]-1,3-thiazol-2-yl]amino]propyl]thiophene-2-carboxamide Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCNC(=O)C1=CC=CS1 SEWOSXUFZVIYDC-UHFFFAOYSA-N 0.000 description 1
- SBRJWIMGKSZESP-UHFFFAOYSA-N n-[4-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]butyl]thiophene-3-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCNS(=O)(=O)C1=CSC=C1 SBRJWIMGKSZESP-UHFFFAOYSA-N 0.000 description 1
- JGWUZIHTSVQLTL-UHFFFAOYSA-N n-[5-[[5-(2-chlorobenzoyl)-1,3-thiazol-2-yl]amino]pentyl]thiophene-2-sulfonamide Chemical compound ClC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=CS1 JGWUZIHTSVQLTL-UHFFFAOYSA-N 0.000 description 1
- FUSWHOWMYXHVSW-UHFFFAOYSA-N n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]thiophene-2-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=CS1 FUSWHOWMYXHVSW-UHFFFAOYSA-N 0.000 description 1
- DXIOIJGDXMRACR-UHFFFAOYSA-N n-[5-[[5-(2-methylbenzoyl)-1,3-thiazol-2-yl]amino]pentyl]thiophene-3-sulfonamide Chemical compound CC1=CC=CC=C1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CSC=C1 DXIOIJGDXMRACR-UHFFFAOYSA-N 0.000 description 1
- GPLUGSGFBSNDRM-UHFFFAOYSA-N n-[5-[[5-(pyridine-2-carbonyl)-1,3-thiazol-2-yl]amino]pentyl]thiophene-2-sulfonamide Chemical compound C=1C=CC=NC=1C(=O)C(S1)=CN=C1NCCCCCNS(=O)(=O)C1=CC=CS1 GPLUGSGFBSNDRM-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- BPGXUIVWLQTVLZ-OFGSCBOVSA-N neuropeptide y(npy) Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 BPGXUIVWLQTVLZ-OFGSCBOVSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- DRINJBFRTLBHNF-UHFFFAOYSA-N propane-2-sulfonyl chloride Chemical compound CC(C)S(Cl)(=O)=O DRINJBFRTLBHNF-UHFFFAOYSA-N 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000003153 stable transfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- ALFAEOYQHCTQTP-UHFFFAOYSA-N tert-butyl N-[4-(dimethylaminomethylidenecarbamothioylamino)butyl]-N-methylcarbamate Chemical compound CN(C)C=NC(=S)NCCCCN(C)C(=O)OC(C)(C)C ALFAEOYQHCTQTP-UHFFFAOYSA-N 0.000 description 1
- AOCSUUGBCMTKJH-UHFFFAOYSA-N tert-butyl n-(2-aminoethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCN AOCSUUGBCMTKJH-UHFFFAOYSA-N 0.000 description 1
- PNQYAMWGTGWJDW-UHFFFAOYSA-N tert-butyl n-(3-aminopropyl)-n-methylcarbamate Chemical compound NCCCN(C)C(=O)OC(C)(C)C PNQYAMWGTGWJDW-UHFFFAOYSA-N 0.000 description 1
- POHWAQLZBIMPRN-UHFFFAOYSA-N tert-butyl n-(3-aminopropyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCCN POHWAQLZBIMPRN-UHFFFAOYSA-N 0.000 description 1
- CLFBORGOMXNXFH-UHFFFAOYSA-N tert-butyl n-(3-isothiocyanatopropyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCCN=C=S CLFBORGOMXNXFH-UHFFFAOYSA-N 0.000 description 1
- ZFQWJXFJJZUVPI-UHFFFAOYSA-N tert-butyl n-(4-aminobutyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCCCN ZFQWJXFJJZUVPI-UHFFFAOYSA-N 0.000 description 1
- OQAPHDIBMRKVSA-UHFFFAOYSA-N tert-butyl n-[4-(carbamothioylamino)butyl]-n-methylcarbamate Chemical compound CC(C)(C)OC(=O)N(C)CCCCNC(N)=S OQAPHDIBMRKVSA-UHFFFAOYSA-N 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical class C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- 230000035924 thermogenesis Effects 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- BSXLLFUSNQCWJP-UHFFFAOYSA-N thiophene-2-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=CS1 BSXLLFUSNQCWJP-UHFFFAOYSA-N 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02004296 | 2002-02-28 | ||
| EP02004296 | 2002-02-28 | ||
| PCT/EP2003/001667 WO2003072577A1 (en) | 2002-02-28 | 2003-02-19 | Thiazole derivatives as npy receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60316411D1 DE60316411D1 (de) | 2007-10-31 |
| DE60316411T2 true DE60316411T2 (de) | 2008-06-12 |
Family
ID=27763338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60316411T Expired - Fee Related DE60316411T2 (de) | 2002-02-28 | 2003-02-19 | Thiazolderivate als npy-rezeptorantagonisten |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6686381B2 (enExample) |
| EP (1) | EP1480976B1 (enExample) |
| JP (1) | JP2005526732A (enExample) |
| KR (1) | KR100611854B1 (enExample) |
| CN (1) | CN100363362C (enExample) |
| AR (1) | AR038704A1 (enExample) |
| AT (1) | ATE373654T1 (enExample) |
| AU (1) | AU2003210305B2 (enExample) |
| BR (1) | BR0308108A (enExample) |
| CA (1) | CA2475299A1 (enExample) |
| DE (1) | DE60316411T2 (enExample) |
| ES (1) | ES2292992T3 (enExample) |
| GT (1) | GT200300045A (enExample) |
| MX (1) | MXPA04008379A (enExample) |
| PA (1) | PA8567301A1 (enExample) |
| PE (1) | PE20030930A1 (enExample) |
| PL (1) | PL372463A1 (enExample) |
| RU (1) | RU2004129285A (enExample) |
| TW (1) | TW200403995A (enExample) |
| UY (1) | UY27689A1 (enExample) |
| WO (1) | WO2003072577A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7144911B2 (en) | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
| US7279576B2 (en) | 2002-12-31 | 2007-10-09 | Deciphera Pharmaceuticals, Llc | Anti-cancer medicaments |
| US7202257B2 (en) | 2003-12-24 | 2007-04-10 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
| MXPA06001570A (es) * | 2003-08-12 | 2006-05-15 | Hoffmann La Roche | Antagonistas del receptor de neuropeptido y (npy) 2-amino-5-benzoiltiazol. |
| EP1656374B1 (en) | 2003-08-12 | 2009-03-11 | F. Hoffmann-La Roche Ag | Thiazole derivatives as npy antagonists |
| ES2298840T3 (es) | 2003-12-08 | 2008-05-16 | F. Hoffmann-La Roche Ag | Derivados de tiazol. |
| MXPA06012130A (es) * | 2004-04-20 | 2007-01-31 | Transtech Pharma Inc | Derivados de tiazol y pirimidina substituidos como moduladores del receptor de melanocortina. |
| FR2884516B1 (fr) * | 2005-04-15 | 2007-06-22 | Cerep Sa | Antagonistes npy, preparation et utilisations |
| EP1981884B1 (en) * | 2006-01-18 | 2012-06-13 | Amgen, Inc | Thiazole compounds as protein kinase b (pkb) inhibitors |
| WO2010098298A1 (ja) * | 2009-02-27 | 2010-09-02 | 塩野義製薬株式会社 | 栄養素の消化吸収抑制作用を有する化合物とシクロヘキサンカルボキサミド誘導体を組み合わせてなる医薬組成物 |
| US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| BR112020015581A2 (pt) | 2018-01-31 | 2021-02-02 | Deciphera Pharmaceuticals, Llc | terapia de combinação para o tratamento de tumores estromais gastrointestinais |
| EP3746060A1 (en) | 2018-01-31 | 2020-12-09 | Deciphera Pharmaceuticals, LLC | Combination therapy for the treatment of mastocytosis |
| WO2021030405A1 (en) | 2019-08-12 | 2021-02-18 | Deciphera Pharmaceuticals, Llc | Ripretinib for treating gastrointestinal stromal tumors |
| KR20220045189A (ko) | 2019-08-12 | 2022-04-12 | 데시페라 파마슈티칼스, 엘엘씨. | 위장관 기질 종양을 치료하는 방법 |
| SMT202300467T1 (it) | 2019-12-30 | 2024-01-10 | Deciphera Pharmaceuticals Llc | Formulazioni di inibitori di chinasi amorfi e loro procedimenti d’uso |
| CN118948773A (zh) | 2019-12-30 | 2024-11-15 | 德西费拉制药有限责任公司 | 1-(4溴-5-(1乙基-7-(甲氨基)-2侧氧基-1,2-二氢-1,6-萘啶-3基)-2氟苯基)-3-苯基脲的组合物 |
| US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1247547A (en) * | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
| CA1328881C (en) | 1984-12-21 | 1994-04-26 | Pierre Barbier | Process for the manufacture of oxetanones |
| CA1270837A (en) | 1984-12-21 | 1990-06-26 | Hoffmann-La Roche Limited | Oxetanones |
| CA2035972C (en) | 1990-02-23 | 2006-07-11 | Martin Karpf | Process for the preparation of oxetanones |
| US5274143A (en) | 1991-07-23 | 1993-12-28 | Hoffmann-La Roche Inc. | Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione |
| AUPN163795A0 (en) | 1995-03-10 | 1995-04-06 | DIPNALL, David | A device for extracting energy from moving water particles |
| US6004996A (en) | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
| US6267952B1 (en) | 1998-01-09 | 2001-07-31 | Geltex Pharmaceuticals, Inc. | Lipase inhibiting polymers |
| DE19824175A1 (de) * | 1998-05-29 | 1999-12-02 | Novartis Ag | Amino-azol-Verbindungen |
| AU761351B2 (en) | 1998-08-14 | 2003-06-05 | Cheplapharm Arzneimittel Gmbh | Pharmaceutical compositions containing lipase inhibitors |
| DE69916288T2 (de) | 1998-08-14 | 2005-03-24 | F. Hoffmann-La Roche Ag | Lipasehemmer und chitosan enthaltende arzneimittel |
| US20010039275A1 (en) * | 2000-02-04 | 2001-11-08 | Bowler Andrew Neil | Use of 2,4-diaminothiazole derivatives |
| AU2001246494A1 (en) * | 2000-03-03 | 2001-09-12 | Novartis Ag | Condensed thiazolamines and their use as neuropeptide y5 antagonists |
| EP1417188A1 (en) * | 2001-08-03 | 2004-05-12 | Novo Nordisk A/S | Novel 2,4-diaminothiazole derivatives |
-
2003
- 2003-02-19 MX MXPA04008379A patent/MXPA04008379A/es active IP Right Grant
- 2003-02-19 CN CNB03804823XA patent/CN100363362C/zh not_active Expired - Fee Related
- 2003-02-19 JP JP2003571283A patent/JP2005526732A/ja active Pending
- 2003-02-19 CA CA002475299A patent/CA2475299A1/en not_active Abandoned
- 2003-02-19 ES ES03742945T patent/ES2292992T3/es not_active Expired - Lifetime
- 2003-02-19 EP EP03742945A patent/EP1480976B1/en not_active Expired - Lifetime
- 2003-02-19 AT AT03742945T patent/ATE373654T1/de not_active IP Right Cessation
- 2003-02-19 PL PL03372463A patent/PL372463A1/xx not_active Application Discontinuation
- 2003-02-19 DE DE60316411T patent/DE60316411T2/de not_active Expired - Fee Related
- 2003-02-19 AU AU2003210305A patent/AU2003210305B2/en not_active Ceased
- 2003-02-19 WO PCT/EP2003/001667 patent/WO2003072577A1/en not_active Ceased
- 2003-02-19 RU RU2004129285/04A patent/RU2004129285A/ru not_active Application Discontinuation
- 2003-02-19 KR KR1020047013315A patent/KR100611854B1/ko not_active Expired - Fee Related
- 2003-02-19 BR BR0308108-7A patent/BR0308108A/pt not_active IP Right Cessation
- 2003-02-25 PE PE2003000182A patent/PE20030930A1/es not_active Application Discontinuation
- 2003-02-25 PA PA20038567301A patent/PA8567301A1/es unknown
- 2003-02-26 GT GT200300045A patent/GT200300045A/es unknown
- 2003-02-26 TW TW092104045A patent/TW200403995A/zh unknown
- 2003-02-26 AR ARP030100627A patent/AR038704A1/es not_active Application Discontinuation
- 2003-02-26 US US10/374,573 patent/US6686381B2/en not_active Expired - Fee Related
- 2003-02-27 UY UY27689A patent/UY27689A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003210305A1 (en) | 2003-09-09 |
| CN1639158A (zh) | 2005-07-13 |
| PA8567301A1 (es) | 2004-02-07 |
| CA2475299A1 (en) | 2003-09-04 |
| DE60316411D1 (de) | 2007-10-31 |
| KR100611854B1 (ko) | 2006-08-11 |
| WO2003072577A1 (en) | 2003-09-04 |
| PL372463A1 (en) | 2005-07-25 |
| JP2005526732A (ja) | 2005-09-08 |
| BR0308108A (pt) | 2004-12-07 |
| MXPA04008379A (es) | 2004-11-26 |
| CN100363362C (zh) | 2008-01-23 |
| TW200403995A (en) | 2004-03-16 |
| GT200300045A (es) | 2003-09-23 |
| ATE373654T1 (de) | 2007-10-15 |
| AR038704A1 (es) | 2005-01-26 |
| ES2292992T3 (es) | 2008-03-16 |
| AU2003210305B2 (en) | 2006-07-06 |
| PE20030930A1 (es) | 2003-11-08 |
| US20030225141A1 (en) | 2003-12-04 |
| EP1480976B1 (en) | 2007-09-19 |
| RU2004129285A (ru) | 2005-10-27 |
| UY27689A1 (es) | 2003-08-29 |
| US6686381B2 (en) | 2004-02-03 |
| EP1480976A1 (en) | 2004-12-01 |
| KR20040094735A (ko) | 2004-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60316411T2 (de) | Thiazolderivate als npy-rezeptorantagonisten | |
| EP2468717B1 (en) | Heterocyclic Amide Compounds Useful as Kinase Inhibitors | |
| KR101504787B1 (ko) | 아졸카복사마이드 화합물 또는 그 염 | |
| JP2009544620A (ja) | 自己免疫疾患及び炎症のためのプロリン尿素ccr1アンタゴニスト | |
| CA2380866A1 (en) | Selective npy (y5) antagonists | |
| AU2003253364B2 (en) | Thiazole derivatives | |
| JP2003524574A (ja) | 2,5−及び3,5−二置換アニリン誘導体、その調製及び使用 | |
| DE602004010529T2 (de) | 2-amino-5-benzoylthiazol npy-antagonisten | |
| KR20080003380A (ko) | 우레아 유도체들, 그 제조방법 및 그 이용 | |
| JP5944483B2 (ja) | アダマンチル基を有するスルファミド誘導体及びこれの薬剤学的に許容可能な塩 | |
| RU2321586C2 (ru) | Производные тиазола в качестве антагонистов npy | |
| DE69010772T2 (de) | 1,2,4-Triazolderivate, ihre Herstellung und ihre Verwendung in der Behandlung von Bluthochdruck oder von Atemwegserkrankungen. | |
| WO2009058919A1 (en) | Ccr5 antagonists as therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |